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Prochlorococcus marinus, a marine cyanobacterium, is one of the most abundant 
photosynthetic organisms in the ocean. P. marinus contributes towards approximately  
8.5% of global ocean primary productivity. P. marinus is of interest because of the cell’s 
simple and unique photosynthetic system, efficient carbon concentrating mechanism, and 
streamlined genome. P. marinus strain MIT9312 is a high-light adapted strain that thrives 
in the upper euphotic zone where there are minimal nutrients and high levels of UV 
exposure, which would typically put an organism at risk. Understanding the function of 
repair proteins is significant for being able to identify the DNA repair pathways used by 
Prochlorococcus to survive under increasingly more harmful conditions. My research, 
outlined in this thesis, aimed to characterize DNA repair enzymes in Prochlorococcus 
marinus strain MIT9312 to further our understanding of cyanobacterial growth, survival, 
and repair. 
 
LigW is an ATP-dependent ligase that is unique to strain MIT9312. It was found to have 
low ligase activity on nicked DNA compared to other ligases, making its retention in the 
small Prochlorococcus genome unusual. It is suspected that LigW could achieve higher 
ligation rates by interacting with other proteins. LigW is in an operon with other proteins 
that are predicted to promote LigW activity or have their own DNA modifying activities. 
The three proteins of interest have been annotated as Pmar3, Pmar4, and Pmar5. The 
individual function and relationships between each protein were investigated in this thesis. 
 
This thesis focused on recombinantly producing and biochemically characterizing three 
of the proteins adjacent to LigW and assessing their activities in vitro. Pmar3 was 
successfully expressed, purified, and characterized as a potential nuclease. Further 
mutagenesis work will confirm the proposed function of Pmar3. Attempts were made to 
characterize Pmar4, with further optimization of expression and purification protocols 
necessary. Pmar5 has been characterized as a pentameric Mg-dependent topoisomerase-
like protein, with an inability to re-join DNA. It is likely that these proteins on the LigW 
operon work together with LigW in a currently unidentified repair pathway. Once the 
LigW DNA repair system is characterized, then this can be more easily identified and 
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Prochlorococcus marinus, a marine cyanobacterium, is one of the most abundant 
photosynthetic organisms in the ocean. P. marinus is thought to contribute towards 
approximately 8.5% of global ocean primary productivity (Laurenceau et al., 2020). Its 
significant contribution to global oxygen production is beneficial for helping other 
organisms to survive. P. marinus is an organism of interest because of the cell’s simple 
and unique photosynthetic system, efficient carbon concentrating mechanism, and 
minimal genome. Prochlorococcus is a good model for naturally occurring ecological 
variation and evolutionary diversification (Prabha et al., 2014). P. marinus strain 
MIT9312 has adapted to thrive in the upper euphotic zone where there are minimal 
nutrients and high levels of UV exposure, which would typically put an organism at risk. 
Little research has focused on genes and proteins involved in DNA repair in 
Prochlorococcus. Understanding the function of repair proteins is significant for being 
able to identify the DNA repair pathways used by Prochlorococcus. Understanding how 
DNA repair enzymes among others within Prochlorococcus function could help us to 
utilize and engineer bacteria to survive under increasingly more harmful conditions, such 
as those caused by climate change. My research aimed to characterize DNA repair 
enzymes in Prochlorococcus marinus strain MIT9312 to assist in furthering our 
understanding of cyanobacterial growth, survival, and repair. 
 
 
1.1 Classification of Prochlorococcus marinus 
Prochlorococcus are commonly found in the euphotic zone between 45°N and 45°S, in 
the tropical and subtropical oligotrophic ocean at surface level and down to depths of 150-
200m (Biller et al., 2015; Flombaum et al., 2013; Partensky et al., 1999). They have 
adapted to be small oligotrophs with minimal energy requirements, to aid their survival 
in these environments which lack macronutrients typically required for photosynthesis 
and cell growth. Prochlorococcus is the smallest known photosynthetic organism, with a 
diameter of 0.45-0.7µm (Partensky et al., 1999; Yan et al., 2020) and an estimated mean 
global abundance of 3x1027 cells (Flombaum et al., 2013; Partensky et al., 1999; 
Schattenhofer et al., 2009). Prochlorococcus has one of the smallest known 
 
2 
photoautotrophic non-symbiotic genomes, with a genome size of 1.6-2.4Mb (Coleman et 
al., 2006; Hess, 2011), GC content of 30.8-50.7% (Kettler et al., 2007), and it contains 
only ~1,700 genes (Rocap et al., 2003). It has a high surface-area:volume ratio, which 
promotes efficient light absorption (Biller et al., 2015), and allows it to dominate 
oligotrophic areas and outcompete other species for nutrients (Laurenceau et al., 2020). 
However, the small genome has been found to lack genes that are present in other species 
of cyanobacteria, including those involved in key processes such as DNA repair and 
photosynthesis (Dufresne et al., 2003). 
 
1.1.1 Habitat and Morphology 
 
Prochlorococcus marinus is a micro-diverse organism that can occupy the entire euphotic 
zone. Subgroups of Prochlorococcus have adapted to survive in different levels of light, 
temperature, and nutrients, so are therefore capable of living at different levels of the three 
gradients. Figure 1-1, shows the light, temperature, and nutrient gradients at different 
depths of the euphotic zone water column. Nutrients and cells are distributed in the upper 
mixed layer by heat and wind turbulence. Without turbulence, both nutrient and 
Figure 1-1: Diagram depicting the euphotic zone of the ocean, which Prochlorococcus 
marinus occupies. The euphotic zone water column is characterized by its light, 
temperature, and nutrient gradients in the lower layers. Different strains of P. marinus 
are located at different levels of the water column, depending on their light, temperature, 
and nutrient requirements (Biller et. al, 2015).  
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temperature gradients form in relation to ocean depth. As the depth increases, light levels 
and temperatures decrease, whereas nutrient concentrations increase (Biller et al., 2015). 
 
Prochlorococcus is an example of a genetically diverse group of organisms that exhibit 
global biogeographical distribution due to its genetic composition and is influenced by 
external environmental factors. Phylogenetic variance has been observed between ocean 
regions, with lineages varying in relative frequencies across regions. Varying nitrate 
concentration and temperature cause most of the phylogenetic diversity across regions, 
while phosphate concentration, light availability, and coastal influence have been found 
to have less of an effect (Kent et al., 2016). Biogeographical patterns of gene content have 
been observed across regions and are similarly mainly influenced by nitrate 
concentrations and temperature. Variances in gene content and phylogenetics in 
Prochlorococcus populations are significantly correlated, indicating that 
phylogenetically similar regions have higher similarity in gene content. This suggests a 
model of vertical inheritance of gene content. Some non-core genes are environmentally 
influenced and have contributed to the existence of different Prochlorococcus lineages in 
different environments (Kent et al., 2016).  
 
1.1.2 Nutrient Acquisition 
Prochlorococcus requires nutrients such as nitrogen and phosphorous for growth and 
survival. Marine picocyanobacteria genomes have adapted to different niches and have 
acquired different methods to metabolise nitrogen depending on the niche they occupy 
and each niche’s nitrogen availability. P. marinus strain MIT9312 is exposed to 
nanomolar concentrations of nitrogen in the surface layer of the oligotrophic (sub)tropical 
ocean (Scanlan et al., 2009). All marine picocyanobacteria are unable to fix dinitrogen as 
they lack the genes that encode nitrogenase. Most nitrogen is obtained by assimilating 
ammonium into organic nitrogen compounds, in addition to other inorganic and organic 
nitrogen compounds. Phosphorous acquisition genes in Prochlorococcus can vary 
between species and within a genus, which suggests that phosphorous acquisition 
strategies differ depending on the environment. Most of these genes are in variable 
genomic islands and it is suspected that Prochlorococcus have adapted over time to their 
environment and have acquired genes for nutrient assimilation via horizontal gene 
transfer (Coleman et al., 2006; Rocap et al., 2003). Prochlorococcus can thrive in areas 
with minimal nutrients, but when starved of light and nutrients for extended periods, 
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Prochlorococcus depends on co-occurring heterotrophic bacteria for survival (Roth-
Rosenberg et al., 2020). 
 
1.1.3 Photosynthesis 
As the most abundant photosynthetic organism on Earth, Prochlorococcus is one of the 
main primary producers in low to mid-latitude oceans (Kettler et al., 2007), contributing 
30-80% of total photosynthesis, and significantly contributing to climate regulation and 
global carbon cycling (Bryant, 2003; Paul et al., 2010). Prochlorococcus and 
Synechococcus are equipped with different photosynthetic systems which are well 
adapted to the different conditions that each species is exposed to. Prochlorococcus uses 
chlorophyll-binding proteins as a light harvesting antenna to harvest divinyl chlorophyll 
a/b pigments, whereas Synechococcus uses phycobilisomes on monovinyl chlorophyll 
pigments (Biller et al., 2015; Kettler et al., 2007; Scanlan et al., 2009; Yan et al., 2020). 
The Pcb (pigment binding) proteins used by Prochlorococcus allows the adaptation of 
different strains to low-light environments (Yan et al., 2020). Divinyl chlorophyll a/b 
pigmentation causes a red-shift in the absorption spectrum, which assists with the 
absorption of blue light, which is dominant in deeper, low-light environments. Different 
Prochlorococcus strains have adapted to varying light levels by adjusting their ratios of 
pigmentation to meet light absorption requirements (Scanlan et al., 2009; Yan et al., 
2020).  
 
1.1.4 Prochlorococcus Ecotypes 
There is significant variation between Prochlorococcus strains, which has resulted in the 
classification of strains by ecotype. There are two ecotypes: high-light (HL) and low-light 
(LL), which are named as such due to the abundance of different strains at the surface and 
deeper levels of the ocean respectively (Prabha et al., 2014). This phenotypical 
classification has been explored further, leading to the discovery of at least 12 major 




The strains comprising these 12 clades have 16s rRNA sequences that have more than 97% 
sequence similarity. Despite the vast difference in traits held by HL and LL strains, 
Prochlorococcus remains as a monophyletic group that is closely related to 
Synechococcus (shown in Figure 1-2). The HL strains form a monophyletic group, 
consisting of six clades (HLI-HLVI), whereas the LL strains for a polyphyletic group, 
also consisting of six clades (HLI-HLVII) (Biller et al., 2015; Prabha et al., 2014; Yan et 
al., 2020).  
   
P. marinus strain MIT9312 is a HLII strain. The HLI and HLII clades consist of the most 
abundant strains, contributing over 90% of the global Prochlorococcus population. The 
HLII strains are located in higher-temperature oceans and can grow at temperatures over 
28oC (Johnson et al., 2006). Physiological studies have confirmed that HL strains grow 
more quickly and efficiently in HL conditions than LL strains, and vice versa (Moore et 
al., 1998).   
 
1.1.5 Prochlorococcus Genomics 
The differentiation of ecotypes is based on the differences in the genomes of different 
strains. Prochlorococcus has a streamlined genome, which formed when the genome 
Figure 1-2: Phylogenetic tree of major Prochlorococcus clades, based on the rRNA 
internal transcribed spacer (ITS) sequences. The five clades highlighted have been 
successfully cultured, the remainder have been identified from environmental sequencing 
(Biller et. al, 2015).  
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decreased in size once the species diverged from Synechococcus (Scanlan et al., 2009). 
This led to the removal of genes that may not have provided a benefit to Prochlorococcus 
that outweighed the cost of retention (Sun & Blanchard, 2014). HL-adapted strains have 
a smaller genome of 1.60-1.80Mbp that encodes 1800-2100 genes, compared to LL-
adapted strains, which are 1.75-1.95Mbp, and encodes 2000-2300 genes (Hess, 2011). 
The genome of the Prochlorococcus genus is described as being an open pan-genome of 
more than 13,000 genes, which consists of ‘core’ and ‘flexible’ sections. The core genome 
consists of essential housekeeping genes and comprises approximately 50% of the 
genome (Kettler et al., 2007). The flexible genes have been described as being part of 
hypervariable genomic islands which different strains draw from and contribute towards 
(Biller et al., 2015; Kettler et al., 2007; Tschoeke et al., 2020). Flexible genes that have 
been retained by different strains are likely to be beneficial for survival in the strain’s 
particular environment and are subject to selection pressure (Biller et al., 2015). 
Horizontal gene transfer often occurs with genomic islands and is a source of new genes 
which allows Prochlorococcus to continuously adapt to its environment.  
 
There is a notable difference in the number of enzymes present in low and high-light-
adapted ecotypes of Prochlorococcus. High-light strains have been found to contain more 
genes related to DNA repair enzymes such as DNA ligases compared to low-light strains 
(Partensky & Garczarek, 2010). P. marinus MIT9312 is a high-light adapted strain that 
thrives in the upper euphotic zone (Zinser et al., 2006), and it contains more DNA 
modifying enzymes than other strains. The function of these additional enzymes is of 
interest because of their retention in the small, minimal Prochlorococcus genome over 
other ‘essential’ enzymes  (Dufresne et al., 2003). 
 
1.1.6 An Evolving Field of Research 
The taxonomy of Prochlorococcus marinus is an active field of research that is rapidly 
evolving. Large-scale sequencing technology has led to the rapid identification of new 
species and genes which make up the Prochlorococcus collective, and the 
Prochlorococcus pan-genome (Tschoeke et al., 2020; Yan et al., 2020). For example, 
since the commencement of this project, 13 new isolates from the HLII clade were 
discovered and sequenced from the western Pacific Ocean and the South China Sea by 
the China University of Geoscience (NCBI accession number: PRJNA611498). In 
contrast to the widely adopted ecology-based classification of Prochlorococcus, a 
 
7 
genomic taxonomy approach has recently led to a proposal of the reclassification of P. 
marinus strain MIT9312 as part of a new genus: Eurycolium, and more specifically, 
Eurycolium neptunius (Tschoeke et al., 2020). This is an example of how our 




1.2 DNA Repair Pathways in Prokaryotes 
DNA repair is an essential process for all living organisms to allow DNA replication and 
gene expression to proceed correctly. As photoautotrophs, Prochlorococcus amongst 
other cyanobacteria are exposed to ultraviolet radiation which although necessary for 
photosynthesis, can be lethal to the organism (Cassier-Chauvat & Chauvat, 2015). DNA 
can easily be damaged by the external environment of organisms, hence the necessity of 
a well-functioning DNA repair system. Cyanobacteria can be severely harmed 
biochemically and physiologically by UV-B irradiation, where metabolic processes, 
growth, development, survival, morphology, pigmentation, and other essential life 
processes are severely affected (Pathak et al., 2019). In addition to UV damage, bacteria 
can develop DNA lesions in response to a range of endogenous and environmental factors. 
Figure 1-3 outlines the main DNA lesion types and the corresponding DNA repair 
pathways that are employed in response. In summary, base excision repair (BER) is 
carried out in response to alkylating agents and oxygen radicals modifying the bases and 
phosphates of DNA. BER is also used for damage caused by spontaneous DNA mutations. 
Nucleotide excision repair (NER) is used to repair DNA adducts and interstrand cross-
links. Errors can arise during DNA replication, and these are repaired by mismatch repair 
(MMR). X-rays can induce double-stranded breaks in DNA, which are repaired by 




Figure 1-3: Different DNA repair systems for primary types of DNA lesions observed in 
prokaryotes (Morita et al., 2010). DNA repair in prokaryotes can be split into three main 
categories: direct reversal, single-stranded break repair, and double-stranded break repair. 
 
1.2.1 Prokaryotic SOS Response 
The SOS response in bacteria occurs in response to increased DNA damage, where DNA 
repair and mutagenesis are initiated. An inducer named RecA, and a repressor named 
LexA, are the two key proteins involved in this response. During normal bacterial growth, 
SOS gene expression is prevented as the LexA repressor binds to the SOS box in the 
promoter region of the SOS genes. When DNA damage increases, RecA filaments form 
at the DNA damage site, which activates self-cleavage of the LexA repressor, enabling 
SOS gene expression. The SOS response is driven by the accumulation of single-stranded 
DNA at replication forks (i.e., the damage site), as DNA polymerase is blocked from 
creating DNA duplexes. As LexA self-cleaves the repression of SOS genes decreases, 
and different DNA repair mechanisms are therefore activated based on the affinity of 
LexA for the SOS box (Kreuzer, 2013; Little & Mount, 1982; Maslowska et al., 2019; 




1.2.2 Direct Reversal of DNA Damage 
DNA damage that is induced by UV light and alkylating agents can sometimes be directly 
reversed without the need for the resynthesis of DNA. Schematic models of both direct 
reversal pathways are shown in Figure 1-4. 
 
UV light induces the formation of additional bonds between two neighbouring pyrimidine 
groups of DNA. Two major photoproducts: cyclobutane pyrimidine dimer (CPD)- and 
(6-4) photoproducts are produced, and without DNA repair, would result in mutagenesis 
and cell death (Ma et al., 2019). The lesions are repaired by two different subgroups of 
Figure 1-4: Schematic models for direct reversal of DNA damage. (a) Recognition and 
repair of cyclobutene pyrimidine dimers by DNA photolyase. (b) Reversal of O6-
alkylated guanines by O6-alkylguanine-DNA alkyltransferase (AGT), or by (c) 
alkyltransferase-like (ATL) proteins. (d) Reversal of N-alkylated by AlkB family 
dioxygenase (Morita et al., 2010). 
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photolyases: CPD- and (6-4) photolyases, which both bind as single proteins to the 
lesions. Photolyases contain a central FAD chromophore which must be fully reduced to 
FADH- for DNA repair to be carried out. Oxidized FAD is converted to FADH- by a 
process called photoreduction, which is activated by light. Light-activated photolyases 
bind to the DNA lesions, where electrons are transferred between the lesion and FADH-. 
This restores the pyrimidines to their monomeric forms, as the pyrimidine dimer and 
cyclobutene bond are broken (Ma et al., 2019; Morita et al., 2010). 
 
Alkylating agents can bind to DNA and form alkylation adducts, which without DNA 
repair could induce mutations and cell apoptosis (Morita et al., 2010). Two direct reversal 
pathways are utilised by bacteria to overcome alkylation damage. The first pathway, 
shown in Figure 1-4 (b), involves O6-alkylguanine-DNA alkyltransferase (AGTs) which 
reverses O6-alkylated guanines. The second pathway, shown in Figure 1-4 (d), utilizes 
AlkB family dioxygenase, which reverses N-alkylated based adducts and lesions which 
can interfere with Watson-Crick pairings (Morita et al., 2010; Yi & He, 2013). AGTs 
transfer alkyl groups from the DNA to a cysteine residue in its active site, resulting in 
deactivation of the AGT and repair of the DNA. Some species of bacteria contain 
homologues of AGT called alkyltransferase-like (ATL) proteins, where the cysteine 
residue is replaced by a different amino acid residue incapable of nucleophilic attack 
(Margison et al., 2007). ATL’s instead bind to O6-alkyl guanine adducts (Figure 1-4 (c))  
and bend the adduct to create a bulky lesion which is repaired via nucleotide excision 
repair (Tubbs & Tainer, 2010). AlkB family dioxygenases carry out oxidative-
demethylation of N1-methyladenine and N3-methylcytosine adducts by utilizing Fe(II), 
O2, and α-ketoglutarate. Oxidative-demethylation results in the oxidation of the alkyl 
groups, release of succinate, formaldehyde, and CO2, and the regeneration of undamaged 




1.2.3 Single-stranded Damage Repair 
Often there will be damage to only one of the strands making up DNA, which means the 
undamaged strand can act as a template for repairing single-stranded breaks. Three repair 
systems are employed by bacteria: base excision repair (BER), nucleotide excision repair 
(NER), and mismatch repair (MMR). 
 
BER is a commonly used DNA repair pathway, as single-base lesions that arise from 
deamination of bases, depurination, depyrimidination, and reactive oxygen species can 
easily be replaced (shown in Figure 1-5). BER is initiated by a DNA glycosylase which 
recognizes the damaged base and hydrolyses the N-glycosidic bond between the base and 
deoxyribose sugar. DNA glycosylases can be either monofunctional or bifunctional, but 
both result in the generation of 3’ OH and 5’ phosphate ends of the abasic (AP) site 
produced by the DNA glycosylase. The AP site generated by a monofunctional DNA 
glycosylase is targeted by apurinic/apyrimidinic endonucleases (APE), which produce 3’ 
OH and 5’ dRP ends. The 5’ dRP end is processed by dRPase to give a 5’ phosphate end. 
In contrast, the AP site generated by the AP lyase activity of the bifunctional DNA 
Figure 1-5: Base excision repair pathway in prokaryotes. (1) DNA glycosylase recognizes 
the recognizes the damaged base and (2) hydrolyses the N-glycosidic bond between the 
base and deoxyribose sugar, producing an abasic (AP) site. (3 and 4) 
Apurinic/apyrimidinic endonucleases target the AP site to produce a 3’ OH and 5’ 
phosphate end. (5) DNA polymerase I adds the required nucleotide. (6) DNA ligase A seals 









glycosylases has a 3’-α,β-unsaturated aldehyde (PA), or a 3’ phosphate end, and a 5’ 
phosphate end. The 3’ ends are produced as the result of β-elimination or β/δ-elimination 
respectively. APE is then required to produce the 3’ OH end. Once the 3’ OH and 5’ 
phosphate ends have been produced, DNA polymerase I then adds the required 
nucleotide, and DNA ligase A seals the nick (Garrett & Grisham, 2017; Kurthkoti et al., 
2020; Morita et al., 2010). 
 
 
Prokaryotic NER is an essential repair mechanism, shown in Figure 1-6, that is used to 
remove UV-induced DNA lesions, such as pyrimidine dimers and bulky adducts. The 
damage site is recognized via one of two mechanisms: global genomic repair (GGR) or 
transcription-coupled repair (TCR). During GGR, DNA lesions are recognized by 
UvrAB, and repair is initiated. In contrast, TCR repair is initiated by a delay in RNA 
polymerase activity. Both pathways lead to the UvRC incising both sides of the lesion to 
remove a 12-13nt oligomer, which is released by UvrD helicase. PolII then synthesizes a 
new strand that is complementary to the excised oligomer, which is then ligated by a DNA 
ligase (Hu et al., 2017; Morita et al., 2010; Sancar, 2016; Truglio et al., 2006).  
 
Figure 1-6: Nucleotide excision repair in E. coli. The damage is recognized by a (UvrA)2 
homodimer, which recruits UvrB to the damage site. An ATP hydrolysis-dependent 
reaction promotes the formation of a UvrB–DNA complex. This complex recruits UvrC, 
which incises 5′ and 3′ to the damage. UvrC and the excised dodecamer (12-mer) are 
released by UvrD helicase. PolII then synthesizes a new strand that is complementary to 
the excised oligomer, which is then ligated by a DNA ligase (Sancar, 2016). 
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Sometimes during DNA replication, the wrong base may be introduced and needs to be 
replaced, warranting the process of MMR. The enzymes involved during MMR can vary 
between species, so MMR in E. coli has been briefly outlined. During MMR a protein 
called MutS binds to the mismatched base to form a MutS-mismatch complex. MutL 
binds to the MutS-mismatch complex to stabilize it, and a restriction endonuclease named 
MutH is activated. MutH nicks the mismatch-containing unmethylated strand of DNA to 
create an excision entry point for a DNA helicase, which excises the mismatch-containing 
region of DNA. DNA polymerase III then synthesizes a new strand which is then ligated 
by a DNA ligase (Morita et al., 2010). 
 
1.2.4 Double-stranded Break Repair 
Double-stranded breaks (DSB) are repaired by two main pathways in prokaryotes: 
nonhomologous end-joining (NHEJ) and homologous recombination (HR). HR is a 
universal pathway and is the main DSB pathway used by bacteria, shown in Figure 1-8. 
In contrast, NHEJ, shown in Figure 1-7, is used by a small number of bacterial species 
that have dormant phases, such as Bacillus and Streptomyces, or spore-forming phases, 
like Mycobacterium and Sinorhizobium. During these phases, bacteria are “single genome 
compartments”, meaning that HR is not possible (Bertrand et al., 2019).  
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Unlike in eukaryotes, NHEJ in prokaryotes involves only two proteins: Ku and a 
multifunctional ATP-dependent ligase, LigD. Ku binds to the 3’ overhanging ends of the 
break and recruits LigD via its polymerase domain (PolDom). PolDom binds to the 
terminal 5’-phosphate group of the DSB and promotes the synapsis and resection of the 
3’ ends of the break. If the overhangs of the DSB are complementary, the overhangs can 
be aligned and religated by the ligase domain of LigD. If the overhangs are not 
complementary, microhomology-mediated DSB repair is carried out by Ku-LigD, where 
areas of homology are aligned. The 3’ overhangs are resected by the nuclease domain of 
LigD, while the PolDom carries out resynthesis of the 3’ ends and ligation of nicks to seal 
the break (Bowater & Doherty, 2006; Pitcher et al., 2007). 
Figure 1-7: NHEJ repair pathway in prokaryotes. (1) The Ku complex binds to the DSB 
site. (2) LigD is recruited to the damage site. (3) DNA end-processing, gap-filling, and 
nucleolytic activities are carried out. The 3’ overhangs are resected by the nuclease 
domain of LigD, while PolDom carries out resynthesis of the 3’ ends. (4) The break is 
sealed by LigD and the NHEJ complex dissociates (Bowater & Doherty, 2006). 
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HR uses an intact copy of the damaged chromosome as a template for DNA synthesis to 
repair the break. One or both ends of the DSB is resected by a 5’ to 3’ exonuclease to 
produce a 3’ ss-tail. A RecA protein catalyses the invasion of the template sister 
chromatid by the 3’ ss-tail. The invading damaged strand pairs with the in-tact strand 
using complementary base-pairing. DNA polymerase uses the damaged strand as a primer 
and replicates the in-tact chromatid to fill and repair the DSB. Any remaining nicks in the 
repaired DNA duplex are sealed by LigA (Shuman & Glickman, 2007). 
 
 
Figure 1-8: HR repair pathway in prokaryotes. Cyan strand of DNA duplex has a DSB 
that is repaired using the sister chromatid (magenta) as a template. (1) RecA catalyses the 
invasion of the sister chromatid by the damaged chromatid. (2) DNA polymerase 
replicates the in-tact strand to repair the DSB. (3) The duplexes separate and LigA seals 






1.3 NAD and ATP-dependent Ligases 
DNA ligases join broken DNA and catalyse the phosphodiester bond formation between 
5’ PO4 and 3’ OH ends of adjacent strands that form the DNA duplex (Lohman et al., 
2011; Shuman, 2009; Timson et al., 2000; Williamson & Leiros, 2020). DNA ligases are 
split into two categories: ATP-dependent or NAD-dependent, which is determined by 
which AMP donor is used during the 3-step phosphodiester bond formation reaction 
(Timson et al., 2000). During the first step, the α-phosphate of either ATP or NAD+ 
undergoes nucleophilic attack by a lysine residue from the catalytic motif of the ligase, 
forming lysine-AMP and releasing pyrophosphate (PPi) or nicotinamide mononucleotide 
(NMN) (Timson et al., 2000; Williamson & Leiros, 2019, 2020). AMP is then transferred 
to the 5’ PO4 end of the DNA to form a pyrophosphate bond. This activates the 5’ 
phosphate for nucleophilic attack by the 3’ OH, forming a new phosphodiester bond and 
releasing AMP (Williamson & Leiros, 2019). 
 
Figure 1-9: The three catalytical steps of the nick-sealing reaction catalysed by DNA 
ligase. Step 1 shows both the ATP and NAD-dependent pathways, which require 
ATP or NAD+ respectively. Steps 2 and 3 are common to both pathways and result 
in the formation of a new phosphodiester bond and the release of AMP (Williamson 
& Leiros, 2020).  
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All bacteria contain NAD+-dependent DNA ligases which are essential for DNA 
replication, with some species also containing ATP-dependent ligases that are used for 
DNA repair (Williamson & Leiros, 2020). ATP-dependent ligases are also used by 
eukaryotes and archaea for replication. The difference in ligase utilization and replication 
machinery is one of the key differences between bacterial and archaeal or eukaryotic cell 
lineages (Doherty & Suh, 2000; Hjerde et al., 2020; Makarova & Koonin, 2013). It 
remains unknown as to why bacteria favour NAD+-dependent ligases (Hjerde et al., 
2020).  
 
1.3.1 DNA Ligases in Prokaryotes 
Prokaryotes contain a variety of DNA ligases that are involved in specific DNA repair 
pathways, summarized in Figure 1-10. 
Figure 1-10: DNA modification pathways in bacteria involving DNA ligases. (A) LigA 
joins Okazaki fragments during DNA replication. (B) Proposed repair pathway including 
LigB. (C) Base excision repair includes LigC in the final ligation step. (D) Different 
domains of the multifunctional LigD are involved at different steps during the repair of 
double-stranded breaks. (E) The function of LigE and the repair pathway it is involved is 
yet to be determined (Williamson & Leiros, 2020). 
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All known bacteria contain a highly conserved NAD+-dependent ligase, LigA, which 
joins Okazaki fragments during DNA replication (Williamson & Leiros, 2020). 
Haemophilus influenzae was one of the first species of bacteria found to contain ATP-
dependent ligases in addition to NAD+-dependent ligases (Cheng & Shuman, 1997; 
Wilkinson et al., 2001). Other human pathogens such as Neisseria meningitidis, Yersinia 
pestis, Vibrio cholerae, Pseudomonas aeruginosa, and Mycobacterium tuberculosis 
contain ATP-dependent DNA ligases (Gong et al., 2004). M. tuberculosis encodes three 
ATP-dependent ligases (LigB, LigC, and LigD), which were successfully characterized 
and have therefore been used as a leading organism in ATP-dependent ligase studies 
(Gong et al., 2004). LigB is efficient at sealing nicks, but the repair pathway involving 
LigB remains to be determined and is expected to be different from existing repair 
pathways. LigB has been found in gene clusters with a novel Lhr-helicase, binuclear 
metallophosphoesterase, and putative exonuclease, suggesting that these enzymes will 
each have a role in a novel repair pathway (Ejaz & Shuman, 2018; Gong et al., 2004; 
Williamson & Leiros, 2020). LigC seals nicks at the end of base-excision repair, which 
is carried out during the stationary-phase of the bacterium. LigD, as previously discussed, 
is a multifunctional ATP-dependent ligase involved in re-joining double-stranded DNA 
breaks. The function of another ATP-dependent ligase, LigE, is still yet to be determined, 
but has an affinity for sealing single-stranded breaks (Williamson & Leiros, 2020). 
 
1.3.2 Ligases in P. marinus MIT9312 
A phylogenomic study of the distribution of ATP-dependent ligases among bacteria 
(Williamson et al., 2016) found that some strains of P. marinus had up to three ATP-
dependent ligases in addition to the highly conserved NAD+-dependent replicative DNA 
ligase (Wilkinson et al., 2001). However, subunits involved with repair pathways that 
utilise ATP-dependent ligases in other organisms are absent (Williamson et al., 2016). A 
comparative genomic study by our group (Hjerde et al., 2020) has shown that ATP-
dependent ligases are not present in low-light strains, while LigP and LigB are present in 
all high-light adapted strains. The genes encoding these high-light specific ligases are an 
example of flexible genes which help these strains to survive in the upper layers of the 
ocean. At the commencement of this master’s project, LigW appeared to only be present 




Figure 1-11: "Presence and absence of ATP- and NAD-dependent DNA ligases in the 13 closed 
genomes of P. Marinus strains with Synechococcus WH7803 as an outgroup”. Strain evolution 
was determined using DNA gyrase B as a gene marker. Ecotypes are classified as high-light (HL) 
or low-light (LL) according to their assignment in ProPortal. Truncated (tr) and full-length (fl) 
NAD-dependent ligases (ND-lig) and ATP-dependent ligases (AD-lig) P, B, and W have been 
identified in different Prochlorococcus strains (indicated by a +). Data is from a pre-print by our 
research group  (Hjerde et al., 2020). 
 
LigB is similar to the LigB found in M. tuberculosis, while the other two ligases are 
unique. These two ligases have been cloned, expressed, and characterized (Williamson & 
Leiros, 2019). One of the ligases, LigP, was found to have a similar structure to other 
ATP-dependent ligases, with a similar alpha-helical N-terminal DNA binding domain to 
the T4 DNA ligase. Lig P was found to also be similar to T4 in being highly active in 
sealing single-strand breaks, but LigP was not effective in sealing double-strand breaks 
(Williamson & Leiros, 2019). The second ligase, LigW, was named as such because of 




LigW was found to have low DNA ligase activity on nicked DNA in comparison to LigP 
and T4 DNA ligase, shown in Figure 1-12 (Williamson, Unpublished). The low levels of 
activity shown by LigW make its retention in the small Prochlorococcus genome unusual. 
It is suspected that LigW could achieve higher rates of ligation by interacting with other 
proteins. This would be like some DNA ligases such as LigD in other species, which 
interacts with the Ku protein present on the LigD operon (Zhu & Shuman, 2007). P. 
marinus does not have a Ku homologue (Williamson et al., 2016) but LigW appears to 
be in an operon with other proteins (shown in Figure 1-13) that are predicted to promote 
LigW activity or have their own DNA modifying activities (Williamson, Unpublished). 
This operon that appears to be unique to the MIT9312 strain contains genes that are  part 
of the flexible genomic island. The three proteins of interest have been annotated as 
Pmar3, Pmar4, and Pmar5. 
 
Figure 1-12: Unpublished data comparing rates of ligation in two of the ATP-dependent 
ligases of P. marinus MIT9312. (a) LigW has low joining activity compared to LigP and 
T4. Activity increases with increasing ligase concentration, but not as significantly as 
another ATP-dependent ligase, LigP. (b) LigW has comparatively low activity and no 
evident affinity for different types of DNA damage. 
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1.4 DNA-modifying proteins in P. marinus MIT9312 
 
Figure 1-13: Putative DNA repair operons of P. marinus MIT9312 including ATP-dependent 
DNA ligases (green) (Williamson, Unpublished). 
 
At the commencement of this research, Pmar5 was annotated as a potential topoisomerase, 
based on sequence homology, whereas the function of Pmar3 and Pmar4 remained to be 
determined. The current details and sequences of these proteins are shown in Appendix 
A. Each protein has a 6-Histidine tag (highlighted in blue), TEV site (highlighted in 
green), and cleavage site (written in red). The 6-Histidine tag at the N terminal gives each 
protein a high binding affinity to nickel. This allows the protein to be separated from 
chaperone Escherichia coli proteins during purifications (Bornhorst & Falke, 2000; 
Janson, 2012).  
 
 
1.5 Research Objectives 
The aim of my master’s research was to recombinantly produce and biochemically 
characterize three of the proteins adjacent to LigW and assess their activities in vitro. The 
following objectives were set to meet this aim: 
1)  Recombinantly produce Pmar3, Pmar4, and Pmar5. This would involve 
optimizing the expression of each protein using an E. coli-based system and 
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optimizing the large-scale purification of each protein using immobilized metal 
affinity chromatography. 
2)  Biochemically characterize Pmar3, Pmar4, and Pmar5 to determine the 
independent function of each protein. This would be achieved through a series of 
function-specific gel-based assays that assess activities including nuclease and 
topoisomerase activity, as well as the ability to bind damaged DNA. 
3) Determine the relationship of each protein with LigW. This would involve ligation 
and gel-based assays that assess how each protein stimulates or modifies the 
activity of LigW. 
 
Characterizing these proteins will help us to understand the significance and purpose of 
LigW. Once the LigW-containing DNA repair system is characterized, then its role and 
distribution in the environment can be more easily identified and understood in other 
organisms where it may not be detected at present. It is hypothesised based on the missing 
Ku homologue and other repair elements, that LigW and the other ATP-dependent ligases 
in P. marinus MIT9312, are involved in a novel repair pathway, and may carry out unique 





Protein Expression and Purification 
2.1 Introduction 
Pmar3, Pmar4, and Pmar5 are unique proteins to P. marinus MIT9312 that are proposed 
to be essential for DNA repair. We wanted to explore the function of each of these genes 
individually in vitro to better our understanding of their purpose and retention in the 
minimal Prochlorococcus genome. 
 
The expression system chosen was an Escherichia coli-based system. This was chosen 
because of its successful application in the recombinant expression of bacterial DNA 
repair proteins in previous studies (Williamson & Pedersen, 2014), including LigP from 
P. marinus (Williamson & Leiros, 2019).  The synthetic constructs were cloned into 
expression vectors pDEST17 and pHMGWA with N-terminal hexahistidine tags and 
TEV sites. The N-terminal hexahistidine tag allows the expressed protein to be purified 
using nickel-immobilized affinity chromatography (Ni-IMAC). TEV protease is able to 
bind to and cleave the TEV site positioned next to the solubility fusion tags (Histidine 
[His] and Maltose Binding Protein [MBP]), allowing fusion tag removal during Ni-IMAC 
(Williamson & Pedersen, 2014).  
 
The plasmids containing the genes encoding the proteins of interest were cloned into a 
DH5α strain, which has an endA1 mutation that inhibits the endonuclease that degrades 
plasmid DNA during plasmid purifications, and a recA mutation which helps to stabilize 
the plasmid by inhibiting homologous recombination (Taylor et al., 1993). The plasmid 
was then transformed into BL21(DE3)pLysS cells for protein expression. These were 
used due to containing the DE3 lysogen, which expresses T7 RNA polymerase, which is 
controlled by the lac UV5 promoter and lacIq (Studier & Moffatt, 1986). Isopropyl-β-D 
thiogalactopyranoside (IPTG) is an analogue of lactose that is used as an alternative to 
lactose to induce T7 RNA polymerase expression by binding to the T7 promoter. When 
IPTG binds, the lac repressor changes shape, dissociates, and allows T7 RNA polymerase 
transcription to proceed. IPTG cannot be broken down by cells and was therefore used 
instead of lactose in the expression system, as it would remain at a constant concentration 
during the expression process. T7 RNA polymerase allows the induction of the otherwise 
repressed expression from T7 promoter containing plasmids such as the two expression 
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plasmids used (pDEST17 and pHMGWA). BL21(DE3)pLysS also contains the pLysS 
plasmid which decreases pre-induction expression by expressing low levels of T7 
lysozyme which controls the T7 promoter (Studier & Moffatt, 1986). Because the pLysS 
and expression plasmids (pDEST17 and pHMGWA) contain chloramphenicol and 
ampicillin resistance genes respectively, culture media was supplemented with 
chloramphenicol and ampicillin to maintain plasmid-containing cells during growth. 
 
Soluble expression of Pmar3, Pmar4, and Pmar5 was attempted by using different fusion 
tags (His and MBP), induction temperatures (15oC and 20oC), and IPTG concentrations 
(0-1mM) as this strategy had previously overcome solubility issues with difficult proteins 
(Williamson & Pedersen, 2014). His and MBP fusion tags were used due to their previous 
success in improving soluble expression of LigW (Williamson, Unpublished) and other 
proteins transformed into E.coli (Niiranen et al., 2007). Soluble expression of 
recombinant proteins can be difficult to achieve, so work was carried out before the 
beginning of this project which focused on identifying favourable expression conditions 
for the proteins of interest. 
 














Pmar3 - - 16.97 - - 
Pmar4 - - 46.13 - - 


































During a 10-week undergraduate research project, I focused on the expression and 
solubility screening of Pmar3, Pmar4, and Pmar5. Six constructs were tested with two 
different IPTG concentrations at two different temperatures (24 samples in total) at a 
small-scale. 5 modified constructs were selected for midi-scale expression and solubility 
screening based on the small-scale results. Nickel pulldowns and midi-scale IMAC’s 
(shown in Figure 2-1) were performed successfully on both Pmar3-MBP and Pmar5-
MBP. This prior research provided an early indication that Pmar3 and Pmar5 could 
successfully be expressed and purified under the following conditions: an MBP fusion 
tag is used, the culture is grown at 37oC until an OD600 of 0.3 is reached and is moved to 
15oC after being induced with a final 0.5mM IPTG concentration.   
 
This chapter uses the findings from this pilot project as a starting point for the 
optimization of large-scale soluble expression and purification of these proteins. 
 
 
2.2 Materials and Methods 
2.2.1 Cloning Pmar3 (WT), Pmar4, Pmar5, and LigW 
Genes encoding Pmar3, Pmar4, and Pmar5 were ordered pre-cloned into pDONR221 
vectors with codon optimization for E. coli from Twist Bioscience. Before the 
commencement of the current research project, the synthetic constructs were cloned into 
Figure 2-1: 12% SDS-PAGE gel from the Midi-scale IMAC's run of 
Pmar3-MBP and Pmar5-MBP. 
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expression vectors pDEST17 and pHMGWA with N-terminal hexahistidine-tags and 
TEV sites. Each plasmid was transformed into E. coli DH5α cells for plasmid storage and 
E. coli BL21(DE3) plysS cells for protein expression. 
 
2.2.2 Cloning Pmar3-mut 
 
 
A mutant of Pmar3 was ordered (hereafter Pmar3-mut) with four point-mutations of 
aspartate to alanine (positions 46, 75, 78, and 140). The Pmar3-mut gene was ordered 
pre-cloned into a pDONR221 vector from Twist Bioscience. The Pmar3-mut synthetic 
construct was sub-cloned into a pHMGWA expression vector with an N-terminal 
hexahistidine-tag and TEV site using the Gateway LR clonase enzyme according to the 
manufacturer’s instructions.  
 
The Pmar3-mut:pHMGWA plasmid was transformed by heat shock into chemically 
competent E. coli DH5α cells for plasmid storage and was plated onto Luria-Bertani (LB)-
agar supplemented with 100µg ml-1 ampicillin. A seeder culture of the transformed cells 
was prepared by inoculating a single colony from a transformation plate of LB agar into 
5ml of LB broth supplemented with 100µg ml-1 ampicillin. The seeder culture was 
incubated overnight at 37oC, shaking at 180rpm. 25% glycerol stocks of the incubated 
seeder culture were prepared and stored at -80oC for long-term use. 
 
Figure 2-2: Pairwise alignment of wild-type Pmar3 and a hypothetical protein from 
Synechococcus lacustris, which returned the most sequence similarity to Pmar3 (24.1%) 
from other organisms. Mutations from aspartate to alanine at positions 46, 75, 78, and 
140 are highlighted with red boxes. 
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The plasmid was purified using a QIAprep® Spin Miniprep Kit (Bio-strategy) according 
to the manufacturer’s instructions. The plasmid was transformed into E. coli 
BL21(DE3)pLysS cells for protein expression as per the methods above. A seeder culture 
of transformed cells was prepared by inoculating a single colony from a transformation 
plate of LB agar into 5ml of LB broth supplemented with 100µg ml-1 ampicillin and 35µg 
ml-1 chloramphenicol. The seeder culture was incubated and 50:50 (w/v) glycerol stocks 
were prepared as per the methods above. 
 
2.2.3 Colony Polymerase Chain Reaction 
Successful transformations were assessed by carrying out colony PCR, using colonies 
from transformation plates, and an MBP forward primer and T7 reverse primer. PCR 
reactions were set up by touching a pipette tip to a colony and dipping it into the master-
mix (shown in Table 2.2), then carried out using an Eppendorf PCR machine (shown in 
Table 2.3) then assessed on a 1% TAE agarose gel. 
 
Table 2.2 Colony PCR Conditions 
Component Concentration 
5x Mastermix (Hotfire Pol Blend) 1x 
10mM Forward Primer 0.3mM 
10mM Reverse Primer 0.3mM 
 
Table 2.3 Colony PCR Cycling Protocol 





 Denature 95oC 0:30 
30 Anneal 55oC 0:20 
 Extend 72oC 0:30 
1 Final Extension 72oC 7:00 
 
The product of the PCR reaction was electrophoresed on a 1% TAE agarose gel to 
determine its size and therefore whether the transformation was carried out successfully. 
The 1% TAE agarose gel was made by dissolving 0.3g agarose in a flask of 30ml 1xTAE 
running buffer (40mM tris-acetate, 1mM EDTA). The flask was microwaved for 30 
second periods and swirled gently, repeating until the agarose was fully dissolved. 3µl 
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SYBRSafe was added and gently swirled to mix, before pouring into a small gel caster. 
A gel comb was inserted, and the gel was left to set for 30 minutes. The set gel was placed 
into a small gel tank which was filled with 1xTAE running buffer. The assay samples 
were prepared for loading by pipette mixing 10µl sample with 2µl 5x DNA loading dye 
(25% glycerol, 0.2% bromophenol blue). 10µl 1kb Plus DNA Ladder bp was loaded into 
the first lane of the gel, and the following lanes were loaded with 10µl of sample per lane. 
Gels were imaged using an iBright imager (Invitrogen). 
 
2.2.4 Midi-scale Expression Testing 
2.2.4.1 Buffer Screening – Pmar4 
Prior research included small-scale screening, which showed that Pmar4 was insoluble in 
all the conditions tested. Therefore, a range of lysis buffer conditions was tested to 
determine whether Pmar4 could be solubilized using different pH’s, reducing agents, and 
salt concentrations. Additionally, both Pmar4-His and Pmar4-MBP were grown at 15oC 
and 20oC. Overnight cultures of Pmar4-His and Pmar4-MBP were prepared at a midi-
scale by adding 5ml of 1xTB broth supplemented with ampicillin (100µgml-1) and 
chloramphenicol (35 µgml-1) to two 15ml loose-capped tubes. Each tube was inoculated 
with one of the Pmar4 glycerol stocks which were thawed on ice. The flasks were 
incubated at 37oC, shaking at 180rpm overnight. Four 150ml flasks were filled with 60ml 
1x concentration TB broth supplemented with ampicillin (100µgml-1) and 
chloramphenicol (35µgml-1). Each flask was inoculated with 1.5ml ONC to give 2 flasks 
per ONC and was put for incubation at 37oC shaking at 180rpm. All four flasks were 
induced with 60µl 0.5M IPTG (final concentration of 0.5mM IPTG) and were transferred 
to 15 or 20oC incubators to incubate overnight, shaking at 180rpm. 
Each flask was split into 6x10ml falcon tubes which were centrifuged at 4570g at 4oC for 
15 minutes. The supernatants were discarded, and the pellets were resuspended with 
2.5ml of relevant buffer (Table 2.4) per 10ml sample volume, and the tubes were 







Table 2.4: Lysis buffer compositions for resuspending Pmar4 expression trial pellets 
Name Composition 
Lysis Buffer A 50mM tris pH8.0, 750mM NaCl, 5% glycerol, 10mM MgCl2 
Low pH 50mM MOPS pH 6.5, 500mM NaCl, 10% glycerol 
High pH 50mM tris pH 9.0, 500mM NaCl, 10% glycerol 
Low Salt 50mM tris pH 8.0, 50mM NaCl, 10% glycerol 
High Salt 50mM tris pH 8.0, 2M NaCl, 10% glycerol 
Reducing 50mM tris pH 8.0, 500mM NaCl, 10% glycerol, 1mM DTT 
 
Samples were sonicated (1/16” tip, amplitude 5, for 3 minutes total, 2 seconds on/2 
seconds off) and centrifuged at 11521g at 4oC for 15 minutes. The pellets and supernatants 
were processed as per methods outlined in section 2.2.4.3. 
 
2.2.4.2 Expression and Solubility Screening – Pmar3-mut 
Overnight cultures of Pmar3-mut were prepared at a midi-scale. 18x 30ml cultures were 
expressed as per the methods outlined in section 2.2.4.1, except falcon tubes were used. 
Each falcon tube was induced with IPTG (outlined in Table 2.5) and incubated overnight 
with shaking at 180rpm.  
 
Table 2.5 Pmar3-mut Growth Conditions 
Sample Temperature OD600 for induction IPTG Final Concentration 
1 15oC 0.3 0.5mM 
2 15oC 0.3 0.75mM 
3 15oC 0.3 1mM 
4 15oC 0.5 0.5mM 
5 15oC 0.5 0.75mM 
6 15oC 0.5 1mM 
7 15oC 0.9 0.5mM 
8 15oC 0.9 0.75mM 
9 15oC 0.9 1mM 
10 20oC 0.3 0.5mM 
11 20oC 0.3 0.75mM 
12 20oC 0.3 1mM 
13 20oC 0.5 0.5mM 
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Sample Temperature OD600 for induction IPTG Final Concentration 
14 20oC 0.5 0.75mM 
15 20oC 0.5 1mM 
16 20oC 0.9 0.5mM 
17 20oC 0.9 0.75mM 
18 20oC 0.9 1mM 
 
Post-incubation, falcon tubes were centrifuged at 4570g at 4oC for 15 minutes. The 
supernatants were discarded, and the pellets were resuspended with 5ml of lysis buffer, 
and the tubes were transferred to ice. Samples were sonicated (1/16” tip, amplitude 5, 3 
minutes total, 2 seconds on/2 seconds off) and centrifuged at 11500g at 4oC for 15 minutes. 
The pellets and supernatants were processed as per methods outlined in section 2.2.4.3. 
 
2.2.4.3 Nickel Pulldown 
The Nickel pull-down method was used for midi-scale samples to provide an early and 
quick indication of successful protein expression. 20µl of nickel beads per sample were 
washed in 1.5ml Eppendorf tubes by adding 1ml lysis buffer A, centrifuging using the 
Eppendorf MiniSpin® plus centrifuge for 1 minute at 1000rpm and disposing of the 
supernatant twice. 200µl lysate was pipette-mixed with 800µl lysis buffer and was added 
to the bead-containing tube for incubation in a thermomixer at 20oC, shaking at 1000rpm 
for 15 minutes. The tubes were briefly spun down to pellet the beads, and the supernatant 
fractions were collected. The beads were washed twice by adding lysis buffer and 
centrifuging for 1 minute at 1000rpm, and the fractions were collected. The beads, wash 
fractions, pellets, and supernatants were loaded onto SDS-PAGE gels (12% resolving gel, 
5% stacking gel for LigW and 12% or 15% resolving gel, 5% stacking gel for Pmar3-
MBP + Pmar5-MBP).  
 
2.2.5 Large-scale Expression 
This protocol was used for the production of proteins Pmar3 (with MBP tag), Pmar5 (with 
MBP tag), and LigW (with His-tag) as these were demonstrated to be expressed in soluble 
form. An overnight 120ml culture (ONC) of the protein of interest was prepared by 
inoculating 1xTB broth, supplemented with ampicillin (100µg/ml) and chloramphenicol 
(35µg/ml), and incubating at 37oC 180rpm overnight. 4x 1L flasks were filled with 1L 1x 
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concentration TB broth, 100µg ampicillin, and 35µg chloramphenicol. Each flask was 
inoculated with 30ml ONC to give 4 flasks per ONC and was put for incubation at 37oC 
180rpm. OD600 measurements were taken hourly from one flask per culture. Each set of 
flasks were moved to 15oC to incubate overnight with shaking at 180rpm once an OD600 
of 0.3 was reached. The flasks were left to equilibrate for 30 minutes before inducing with 
0.5mM IPTG per flask. The total culture was equally poured into pots and centrifuged at 
4570g at 4oC for 20 minutes. The supernatant was discarded, and the pellets were 
collected and weighed in falcon tubes. Tubes were labelled and stored at -20oC for future 
use. 
 
2.2.6 Lysis of Cell Pellets for Purification 
Pre-prepared frozen pellets (see section 2.2.5) were re-suspended on ice by adding 5ml 
lysis buffer A per 1g of pellet. The pellet was transferred to a beaker and sonicated (1/4”, 
amplitude 3, 5 minutes total, 1 second on/1 second off). Sonicated samples were 
transferred to centrifuge tubes and were centrifuged at 11521g for 1 hour at 4oC. The 
supernatant was decanted and collected for purification. The pellet was transferred to a 
fresh falcon tube to be prepared for loading onto SDS-PAGE gels. The supernatant was 
filtered through 1.2 µm, 0.45 µm, and 0.2 µm Minisart filters. 
 
2.2.7 Purification of LigW 
2.2.7.1 IMAC of LigW 
A LigW-His expression culture pellet (see section 2.2.5) was prepared for purification 
(see section 2.2.6). The lysate had 10mM final concentration of imidazole added to help 
decrease the background expression of non-specifically bound E. coli proteins, before 
being loaded into a 50ml super-loop. The filtered supernatant was loaded onto a 5ml 
HisTrap HP column (GE Healthcare Life Sciences) pre-equilibrated with purification 
buffer A (50 mM Tris pH 8.0, 750 mM NaCl, 5% glycerol, 10 mM imidazole), connected 
to the ÄKTAprime plus (GE Healthcare Life Sciences) for immobilized metal affinity 
chromatography using a super-loop, with a flow rate of 2.5ml min-1. The HisTrap HP 
column was washed with 5 column volumes of purification buffer A to remove any 
unbound proteins. Bound proteins were eluted by running a 50ml purification buffer B 
(50 mM Tris pH 8.0, 750 mM NaCl, 5% glycerol, 500mM imidazole) gradient from 0-
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100% at 2.5ml min-1. The crude insoluble, crude soluble, flow-through, and eluted 
fractions were loaded onto SDS-PAGE gels (see section 2.2.11.1). 
 
2.2.7.2 De-salting and TEV Cleavage  
Protein-containing fractions were pooled and loaded onto a pre-equilibrated HiPrepTM 
26/10 de-salting column (GE Healthcare Life Sciences) connected to the ÄKTAprime 
plus (GE Healthcare Life Sciences) at 4.0ml min-1 with TEV cleavage buffer (50mM tris 
pH 8.0, 100mM NaCl, 5% glycerol, 1mM DTT, 0.5mM EDTA. Hereafter buffer C). 
Fractions from the A280 peak on the chromatogram were pooled into falcon tubes, and a 
sub-sample for loading onto SDS-PAGE was collected. The pooled de-salted fractions 
had 1mg TEV protease added. TEV protease was thawed on ice before addition to the 
sample. A pre-cleavage sub-sample for loading onto SDS-PAGE was also collected. The 
sample was incubated on a tilting mixer at 4oC overnight. 
 
2.2.7.3 Reverse IMAC of LigW 
After incubation, the sample was divided into Eppendorf tubes and centrifuged in a 
Thermo Scientific™ Fresco™ 21 Microcentrifuge at 13,500rpm at 4oC for 10 minutes to 
remove any precipitated protein. The supernatant was collected and pooled to load onto 
a 5ml HisTrap HP column (GE Healthcare Life Sciences) pre-equilibrated with buffer C, 
connected to the ÄKTAprime plus (GE Healthcare Life Sciences) for reverse 
immobilized metal affinity chromatography using a super-loop, with a flow rate of 2.5ml 
min-1. The HisTrap HP column was washed with 5 column volumes of buffer C to elute 
the de-tagged protein. The His-tag, TEV protease, and residual contaminating proteins 
were then eluted by running a 25ml purification buffer B gradient to 0-100% at 2.5ml 
min-1. The desalted pooled sample, pre-cleavage sample, overnight cleaved sample 
insoluble and insoluble samples, reverse His-trap flow-through and reverse His-trap elute 
were loaded onto SDS-PAGE gels (see section 2.2.11.1). 
 
Successfully purified flow-through fractions were pooled and concentrated to a final 
volume of 5ml using an Amicon® Ultra-4 10000 MWCO Centrifugal Filter (Merck), pre-
equilibrated with buffer C. The fractions were loaded into the concentrator and were 
centrifuged repeatedly at 3500rpm in 5-minute increments at 4oC using a Heraeus 
Multifuge 3 S-R Refrigerated Centrifuge with a swinging bucket rotor until a volume of 




2.2.7.4 Size Exclusion of LigW 
The concentrated flow-through fractions were loaded onto a Superdex75 16/60 gel 
filtration column (GE Healthcare Life Sciences) pre-equilibrated with buffer C, 
connected to the ÄKTAprime plus (GE Healthcare Life Sciences), for size exclusion. The 
column was washed with 1 column volume of buffer C at 0.5ml min-1. The pooled reverse 
IMAC sample, concentrated reverse IMAC sample, and fractions from each size-
exclusion peak were loaded onto SDS-PAGE gels (see section 2.2.11.1). 
 
2.2.7.5 Storage of Purified LigW 
Purified protein from size exclusion was concentrated to 5.54mg/ml to be used for future 
assays, using an Amicon® Ultra-4 10000 MWCO Centrifugal Filter (Merck). 
Approximately 1ml pure protein was stored using two methods. 1) 500µl of protein was 
diluted with an equal volume of glycerol and was split into 100µl aliquots in PCR tubes. 
2) The remaining 500µl was directly transferred into PCR tubes in 100µl aliquots and 
was flash-frozen using liquid nitrogen. All PCR tubes were labelled and stored at -80oC. 
The final concentration of purified protein was quantified from A280 measurements taken 
using a NanodropTM. 
 
2.2.8 Optimization of Purification of Pmar3 
Optimization of the purification of Pmar3 was required to achieve a high yield of 
concentrated, pure protein. Adjustments were made to the purification method to help 
increase MBP-tag cleavage, de-tagged Pmar3 yield, and concentration of Pmar3. 
 
2.2.8.1 IMAC Purification with Dialysis 
A Pmar3-MBP expression culture pellet (see section 2.2.5) was prepared for purification 
(see section 2.2.6). IMAC of Pmar3-MBP was carried out as per section 2.2.7.1, except a 
1ml His-trap was used with a flow rate of 1ml min-1. De-salting of Pmar3-MBP was 
carried out after the initial IMAC using dialysis methods to try to remove some 
contaminants. The 5ml lysate from protein-containing fractions was placed in a dialysis 
bag with a 6-8kDa molecular weight cut-off, which was incubated in 500ml buffer C on 
a stir-plate, overnight at 4oC. The next day, 0.4mg TEV protease was added to the dialysed 
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sample and was left to incubate for 6 hours at 4oC. Sub-samples were taken every 2 hours 
to load onto SDS-PAGE to observe TEV cleavage progression. A reverse IMAC was run 
after 6 hours of incubation with TEV according to section 2.2.7.3.  
 
2.2.8.2 IMAC Purification with De-salting 
A Pmar3-MBP expression culture pellet (see section 2.2.5) was prepared for purification 
(see section 2.2.6). Purification of Pmar3-MBP was carried out as per section 2.2.7.1, 
including buffer exchange via desalting with the HiPrep 26/10. The only modification to 
this method was that the post-TEV incubated sample was aliquoted into Eppendorf tubes, 
which were centrifuged in a Thermo Scientific™ Fresco™ 21 Microcentrifuge at 
13,500rpm for 10 minutes at 4oC to pellet precipitants, and only the lysate was loaded on 
to reverse IMAC.  
 
2.2.8.3 TEV Cleavage Optimization 
A Pmar3-MBP expression culture pellet was prepared for IMAC from a 250ml culture 
(see sections 2.2.5 and 2.2.6). IMAC and de-salting of Pmar3-MBP were carried out as 
per sections 2.2.7.1 and 2.2.7.2. TEV cleavage samples were set up in 40µl reaction 
volumes, with 1:5 and 1:10 TEV protease:Pmar3-MBP ratios, 4oC, RT, and 37oC 
incubation temperatures, and 30 minutes, 1 hour and overnight timepoints (see Appendix 
B), to identify which conditions provide the best yield of cleaved Pmar3. 
 
2.2.8.4 Optimized Purification of Pmar3 
Pmar3 was purified using the methods outlined in section 2.2.8.2. The elution peak from 
the reverse IMAC was processed through an additional second TEV cleavage step at 4oC 
overnight and a second reverse IMAC. These steps were repeated to help increase the 
cleavage of the MBP-tag from Pmar3-MBP and increase the yield of cleaved Pmar3. 
 
2.2.9 Re-folding and IMAC Purification of Pmar4 with Urea  
A Pmar4-His expression culture pellet (see section 2.2.5, except 500ml was grown) was 
prepared for purification. The pellet was re-suspended on ice by adding 20ml lysis buffer 
(50mM tris pH8.0, 750mM NaCl, 5% glycerol, 10mM imidazole). The pellet was 
transferred to a beaker and sonicated (1/4”, amplitude 12, 3 minutes total, 1 second on/1 
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second off). Sonicated samples were transferred to small pots and were centrifuged at 
11500g for 1 hour at 4oC. The supernatant was decanted and collected for SDS-PAGE. 
The pellet was transferred to a fresh falcon tube, re-suspended in 20ml wash buffer (lysis 
buffer + 1% Triton-X), and centrifuged (4570g, 20min, 4oC). The supernatant was 
decanted and collected for SDS-PAGE. The pellet was dissolved in 5ml denaturation 
buffer (lysis buffer + 8M urea) and centrifuged (4570g, 1hr, 4oC). The supernatant was 
collected in a syringe and was dropwise diluted into a beaker of 45ml (10x supernatant 
volume) lysis buffer to give a final 0.8M urea concentration, and to re-fold Pmar4-His. 
The supernatant was filtered through 1.2 µm, 0.45 µm, and 0.2 µm Minisart filters. 
 
IMAC of Pmar4-His was run as per section 2.2.7.1, except the ÄKTA purifier at RT was 
used to prevent the crystallisation of urea. Protein-containing fractions were pooled, 
concentrated (see section 2.2.7.3), and size excluded as per section 2.2.7.4, except a 
BioRad NGC system at RT was used. 
 
2.2.10 Optimization of Purification of Pmar5 
2.2.10.1 IMAC Purifications at 4oC 
A Pmar5-MBP expression culture pellet (see section 2.2.5) was prepared for purification 
(see section 2.2.6), which was carried out using the steps outlined in section 2.2.7. The 
methods were adjusted to include a 30-minute RT TEV protease incubation step before 
incubation overnight at 4oC. The reverse IMAC was repeated with the elution fractions 
of the first reverse IMAC, as Pmar5 did not appear in the flow-through. The repeated 
reverse IMAC included re-loading the supernatant, a 25ml buffer C wash, 50ml buffer A 
wash, and a 50ml gradient from 0 to 100% buffer B. Size exclusion of the flow-through 
was attempted. 
 
A second purification was carried out at 4oC using the methods stated above. However, 
incubation with TEV protease was carried out at 4oC overnight only and resulted in visible 
precipitation of the protein. A reverse IMAC was attempted using the supernatant, and 
size exclusion was not completed. 
 
A third purification was carried out at 4oC using the methods stated above. Incubation 
with TEV protease was carried out in Eppendorf tubes on a rotating wheel at 4oC 
overnight. The reverse IMAC included loading the pooled supernatant, a 25ml buffer C 
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wash, 50ml buffer A wash, and a 50ml gradient from 0 to 100% buffer B. Size exclusion 
was not completed. 
 
2.2.10.2 IMAC Purification at Room Temperature 
A Pmar5-MBP expression culture pellet (see section 2.2.5) was prepared for purification 
(see section 2.2.6), except 1µl Benzonase per 10ml lysate was added before sonication to 
decrease DNA contamination. IMAC was carried out as per sections 2.2.7.1 and 2.2.7.2, 
except the room-temperature BioRad NGC system was used for the entirety of the 
purification. The pooled de-salted fractions were incubated with TEV protease for 1 hour 
at RT, then split into Eppendorf tubes for incubation at 4oC overnight. Reverse IMAC 
was skipped, and the post-TEV samples were pooled and concentrated (see section 
2.2.7.3) to be size excluded (see section 2.2.7.4). Protein-containing fractions from size 
exclusion were pooled and incubated with TEV protease for 1hr at 37oC, then 4oC for 2 
days to attempt further de-tagging of Pmar5-MBP. A reverse IMAC was performed 
manually using a syringe, where the protein was loaded, followed by a 25ml buffer C 
wash, and a 25ml buffer B wash.  
 
2.2.10.3 IMAC Purification with Glutathione Redox Buffer 
A Pmar5-MBP expression culture pellet (see section 2.2.5) was prepared for purification 
(see section 2.2.6), which was carried out using the steps outlined in section 2.2.7. The 
methods were adjusted to use a different dialysis buffer; glutathione redox buffer (500mM 
tris pH 8.0, 100mM NaCl, 5% glycerol, 0.5mM EDTA, 0.3:0.03mM glutathione redox) 
and was completed at RT using the BioRad NGC system. Size exclusion was not 
completed. 
 
2.2.10.4 Modified IMAC Purification at 4oC 
A Pmar5-MBP expression culture pellet (see section 2.2.5) was prepared for purification 
(see section 2.2.6). Modifications included two post-sonication centrifuge steps. The first 
centrifugation was at 11521g, 4oC, 45 minutes. The lysate was decanted and collected to 
be centrifuged for a further 20 minutes. IMAC was carried out as per section 2.2.7.1. 
Protein-containing fractions from the IMAC were pooled and concentrated to 4ml final 
volume for size exclusion (see section 2.2.7.4). The protein-containing fractions were 
pooled, and half of the protein-containing fractions (approximately 7ml) were incubated 
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with 0.84mg TEV protease overnight at 4oC. Reverse IMAC was carried out the following 
day (see section 2.2.7.3). 
 
2.2.11 Protein Analysis Methods 
2.2.11.1 SDS-PAGE 
A Hoeffer five gel multi-gel caster was used to cast SDS-PAGE. 12% or 15% resolving 
gel solution was made (Table 2.6) and poured into the gel plates, approximately 2cm from 
the top. Each gel was overlaid with 2ml isopropanol and was left to set at room 
temperature for 40 minutes. Once set, the isopropanol was decanted off the gels and rinsed 
with water, before overlaying each gel with approximately 2ml 5% stacking gel (shown 
in Table 2.6). Gel combs were inserted into each gel, and the gels were left to set at room 
temperature for 30 minutes. 
 








ddH2O 10.05ml 7.05ml 8.5ml 
30% Acrylamide 12.00ml 15.00ml 2.125ml 
Resolving Buffer (1.5M 
Tris, pH 8.8) 
7.50ml 7.50ml - 
Stacking Buffer (1.0M 
Tris, pH 6.8) 
- - 1.6ml 
10% SDS 0.30ml 0.30ml 0.125ml 
10% APS 0.15ml 0.15ml 0.063ml 
TEMED 0.015ml 0.015ml 0.0063ml 
 
Samples were prepared for loading onto SDS-PAGE by mixing 5µl 4xSDS loading dye 
(250mM Tris-HCl pH 6.8, 20% glycerol, 4% SDS, 10% mercaptoethanol, 0.025% 
bromophenol blue) with 15µl sample in PCR tubes and boiling at 95oC for 10 minutes. 
10µl Precision Plus Protein™ standard was loaded in the first lane of the gel, and the 
following lanes were loaded with a 10µl sample per lane. The gels were run at 30mA 
using 1x TG-SDS running buffer (25mM Tris, 250mM glycine, 0.1% SDS).  
Once run, the gels were post-stained with Fairbanks A stain (0.05% Coomassie Blue, 25% 
isopropanol, 10% acetic acid). Fairbanks A stain was poured over the gels, boiled by 
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microwaving for 30 seconds, and was left to stain by shaking for 5 minutes at room 
temperature. Background staining was then removed by de-staining with Fairbanks de-
staining solution (10% acetic acid), which was also boiled for 30 seconds and left to shake 
for 5 minutes. Gels were imaged using an iBright imager (Invitrogen). 
 
2.2.11.2 Native-PAGE 
Native-PAGE gels were poured as per the same method for SDS-PAGE gels, except with 
12% acrylamide (i.e., without the 5% stacking layer) and without the addition of SDS. 
Samples were prepared for loading by mixing 4µl 5x native loading dye (300mM Tris-
HCl pH 6.8, 50% glycerol, 0.05% bromophenol blue) with 16µl sample in PCR tubes. 
10µl Precision Plus Protein™ standard was loaded in the first lane of the gel, and the 
following lanes were loaded with a 10µl sample per lane. The gels were run at 30mA 
using 1xTris-Glycine running buffer (25mM Tris, 250mM glycine). Gels were stained 
and visualised as per section 2.2.11.1. 
 
2.2.12 Mass Spectrometry  
Liquid chromatography–mass spectrometry (LC-MS/MS) was used to confirm the 
protein identity of the final purified product of the Pmar3 and Pmar5 purifications. This 
service was carried out by MS3 Solutions according to company protocols. In summary, 
protein bands of interest were excised from SDS-PAGE gels and were processed using 
an in-gel tryptic digestion method. The tryptic peptides were extracted and detected by 
LC-MS/MS. The spectral data was searched against a database of E. coli protein 
sequences and against the Pmar3 and Pmar5 sequences. 
 
 
2.3 Results and Discussion 
2.3.1 Pmar4 Expression Trial 
Before the commencement of this research, attempts were made to express Pmar4-His 
and Pmar4-MBP but resulted in inclusion bodies. This led to a midi-scale expression trial 
using six different buffers (lysis buffer A, low pH, high pH, low salt, high salt, and 
reducing) in place of lysis buffer A. This was done to see if using different buffers to lyse 
Pmar4 containing cells could help stabilize the protein better than lysis buffer A, which 
was used for both Pmar3 and Pmar5. A nickel pull-down was performed for all twenty-
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four constructs, and the pellets, supernatants, washes, and beads were loaded on to 12% 
SDS-PAGE gels. 
 
Figure 2-3 shows that Pmar4-His was consistently observed in the insoluble fractions but 
did not show any solubilization or nickel bead binding, despite the use of different lysis 
buffers. There was no expression of Pmar4-MBP observed in any of the constructs at any 
point. This suggests that Pmar4 may need to be re-transformed into E. coli BL21 plysS 
cells using a different fusion tag in the future to increase the solubility of Pmar4. 
Alternatively, different growth and lysis methods could be attempted in the future with 





Figure 2-3: 12% SDS-PAGE gels of the Expression Trial and Nickel Pulldowns for Pmar4-His (50kDa) 
and Pmar4-MBP (91kDa). P = Pellet, S = Supernatant, B = Ni Beads, W1 = Wash 1, W2 = Wash 2.  
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2.3.2 Pmar3(mut) Transformation and Expression Trial 
 
The Pmar3 mutant where four aspartic acid residues were mutated into alanine was 
subcloned into pHMGWA and then successfully transformed into E. coli 
BL21(DE3)pLysS cells. This was confirmed by colony PCR, where an MBP forward 
Figure 2-4: pHMGWA-pDONR221-Pmar3 expression clone. Pmar3-mut 
was designed with an MBP forward primer, T7 terminal primer, and 
flanking attB sites, allowing the PCR product to be cloned by pDONR221 to 
generate an entry clone. An LR reaction of Pmar3-mut-pDONR221 was 
carried out to express Pmar3-mut in a pHMGWA destination vector. The 




primer and T7 reverse primer were used to amplify the DNA from the transformed DH5α 
and BL21(DE3)plysS cells. Figure 2-5 shows a 1% TAE agarose gel of the PCR products. 
 
The PCR product size for the successful transformation of Pmar3-mut into BL21plysS 
cells was predicted, using Geneious Prime software, to be 660bp. Figure 2-5 shows that 
the PCR product produced was the correct size and therefore, Pmar3-mut was 
successfully transformed. 
  




An expression trial of Pmar3-mut including 18 conditions was carried out and 18 nickel 
pulldowns were performed. The conditions tested included the conditions that had been 
proven to be successful for Pmar3-MBP, as well as a range of temperatures (15oC and 
20oC), and OD600 levels (0.3, 0.5, and 0.9) before inducing with different IPTG 
concentrations (0.5, 0.75, and 1mM). Different OD600 levels and IPTG concentrations 
were used to test how induction during different bacterial growth phases may affect 
protein expression. Figure 2-6 shows that Pmar3-mut was not successfully expressed in 
the pellet or supernatant, and therefore did not bind to the nickel beads. The pellets 
appeared to contain a large amount of cellular material such as non-specific proteins, 
which make it difficult to resolve the bands, and it is possible that insoluble expression 
of the mutant could be hidden by these. Further expression trials are required to identify 
favourable conditions for the expression of Pmar3-mut. In these future trials, DNase will 
be added to help degrade contaminating DNA, and the pellets will be diluted before 
loading on to SDS-PAGE to help resolve protein bands. 
 
2.3.3 Purification of LigW 
To understand how LigW functions and how it interacts with other proteins, purification 
of stable, soluble LigW was required. LigW had been purified successfully in previous 
Figure 2-6: 15% SDS-PAGE gels of the Expression Trial and Nickel Pulldowns for 
Pmar3-mut-MBP (64kDa). P = Pellet, S = Supernatant, B = Ni Beads. 
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work before the commencement of this project, and a new purification was conducted to 
provide protein for the present project. LigW has previously been purified and kept stable 
at cold temperatures, so purification was carried out at 4oC to increase stability. LigW 
was successfully purified by IMAC, reverse IMAC, and size exclusion.  
 
 
Figure 2-7: IMAC purification and protein analysis of LigW. (a) Chromatogram from 
IMAC of LigW show the UV absorbance (280nm) and elution of LigW-His at 40-50% 
buffer B. (b, c) Chromatograms from sequential reverse IMAC’s of LigW (b) excluding 
and (c) including a buffer A wash step to remove contaminating proteins. Chromatograms 
show UV absorbance (280nm) of LigW in the flowthrough, and the His-tag and other 
contaminating proteins in the elution peak. (d) Chromatogram showing the UV 
absorbance (280nm) of LigW (peak 2) and contaminating proteins (peaks 1, 3 and 4). 
Spikes in the chromatogram are due to electronic noise from the purification instrument. 
(e) 12% SDS-PAGE gel showing the successful de-tagging of LigW using TEV protease 
(flowthrough) and separation from remaining LigW-His and contaminating proteins 
(elution). (f) 12% SDS-PAGE gel showing the size exclusion of LigW (43kDa) from 
remaining LigW-His (47kDa).  













(e)      (f) 
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The IMAC chromatogram shown in Figure 2-7 (a) shows that LigW-His eluted at 
approximately 40-50% buffer B, which corresponds to 200-250mM imidazole. The 
flowthrough and first 40% of the buffer B gradient contained unbound, non-specific 
proteins, which continued to be removed with each step of the purification method. The 
protein-containing fractions (from 40-50% buffer B) were collected, pooled together, and 
run through a de-salting column using buffer C (see Appendix C), before being incubated 
with 1mg TEV protease at 4oC overnight. Visible precipitation was observed in the 
sample after overnight incubation, so the lysate was separated from precipitants by 
centrifugation and was used for the reverse IMAC. The chromatogram shown in Figure 
2-7 (b) corresponds to the first reverse IMAC run of the de-tagged LigW lysate. The SDS-
PAGE gel in Figure 2-7 (e) shows that a mixed population of LigW (43kDa) and LigW-
His (47kDa) was present in the flowthrough, and the eluted peak contained bound LigW-
His and non-specific proteins. The mixed population in the flowthrough suggests that 
some LigW-His was unable to bind to the Ni column. The flowthrough was collected, 
pooled together, and run through a second reverse IMAC to attempt to separate the LigW 
and LigW-His populations. Figure 2-7 (c) shows the chromatogram of the second reverse 
IMAC. This included a buffer A wash step (from 39-79ml total volume) to help recover 
any residual de-tagged LigW that may have non-specifically bound to the Ni column 
under low-salt conditions created by buffer C. The flowthrough from the second reverse 
IMAC was collected, pooled together, and concentrated to give a total volume of 3ml 
which was used for size exclusion. Figure 2-7  (d and f) shows that LigW (peak 2) was 
successfully separated from LigW-His (peak 1) and non-specific proteins (peaks 3 and 4, 
see Appendix C). Peak 2 (55-63ml run volume) was concentrated to a final concentration 
of 5.54mg/ml and was stored for future use in characterization assays. 
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2.3.4 Purification of Pmar3 
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mobility shift and 
coupled ligation 
assays, pH stability 
thermal-shift assay. 
1 Flowthrough was concentrated to a final volume of 4ml and run through size exclusion. Size exclusion product was concentrated to give 1-P3. 
2 Flowthrough was concentrated to a final volume of 4ml and run through size exclusion. Size exclusion product was concentrated to give 2-P3. 
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Attempts to purify Pmar3 at a large-scale had been made before the commencement of 
this master’s project, yet none were successful. This meant that optimization of the 
purification protocol to obtain stable, soluble, and active Pmar3 was required 
(summarized in Table 2.7). Pmar3 was successfully purified using IMAC, reverse IMAC, 
and size exclusion at 4oC. 
 
Several attempts were made to obtain sufficient Pmar3 for characterization experiments. 
The first large-scale purification yielded sufficient pure protein for liquid 
chromatography-mass spectrometry (LC-MS). The details for this purification are shown 
in Appendix C. 
 
 
The protein obtained from attempting to purify Pmar3 initially was confirmed to be Pmar3 
by carrying out LC-MS. The spectra data obtained for the protein band in lane 14 of the 
SDS-PAGE gel shown in Figure 2-8 matched the amino acid sequence for Pmar3. Given 
this confirmation, a second attempt was made at purifying Pmar3 from a Pmar3-MBP 
culture. Purification of Pmar3 was repeated a further two times to try and increase the 
yield and purity of the final protein so it could be characterized as accurately and 
extensively as possible. 
 
 
Figure 2-8: 12% SDS-PAGE gel for the size exclusion of Pmar3. The highlighted band at 





To combat obtaining a low yield of Pmar3 from a large volume of Pmar3-MBP culture, 
a TEV cleavage assay was carried out to determine which incubation conditions of 
Pmar3-MBP with TEV protease would give the highest yield of cleaved Pmar3 product. 
The Pmar3-MBP used in this assay was processed through an IMAC and de-salt step 
before TEV incubation. Protein analysis by SDS-PAGE in Figure 2-9 shows consistent 
MBP-tag cleavage across all 26 trialled conditions. Despite processing the Pmar3-MBP 
lysate through IMAC and de-salt steps before incubation with TEV protease, the IMAC 
elution peak shown in lane 1 appears to contain many contaminating non-specific 
proteins. The contaminants may have interfered with the access of TEV protease to the 
TEV cleavage site on Pmar3-MBP. It was concluded that the next purification of Pmar3 
from Pmar3-MBP would be carried out using incubation conditions of 4oC overnight, as 
this was used successfully with LigW-His. Future steps to optimize the yield of Pmar3 
could include a repetition of this experiment. 
 
Figure 2-9: 15% SDS-PAGE gel of 13 different TEV cleavage conditions. Ratios of 1:5 
then 1:10 TEV Protease:Pmar3-MBP were incubated under each set of conditions. 






Figure 2-10: Second IMAC purification and protein analysis of Pmar3. (a) 
Chromatogram from IMAC of Pmar3 showing the UV absorbance (280nm) and elution 
of Pmar3-MBP at 17-40% buffer B. (b) Chromatogram from the first reverse IMAC of 
Pmar3, showing the UV absorbance of Pmar3 in the flowthrough, and the MBP-tag, 
Pmar5-MBP and other contaminating proteins in both the flowthrough and elution peaks.  
(c) 15% SDS-PAGE gel showing a low yield of isolated Pmar3 and the retention of non-
specific proteins in the flowthrough. (d) Chromatogram of the second reverse IMAC 
showing the UV absorbance of Pmar3 in the flowthrough, and the MBP-tag, Pmar3-MBP 
and most other contaminating proteins in the elution peak. (e) 15% SDS-PAGE gel 
showing the separation of Pmar3 (17kDa) from Pmar3-MBP (64kDa). Bands are marked 
with arrows. (f) Chromatogram showing the UV absorbance of Pmar3 (Pmar3-containing 
peak is indistinguishable due to instrument malfunction). (g) 15% SDS-PAGE gel showing 







A second purification of Pmar3-MBP was attempted. The IMAC chromatogram shown 
in Figure 2-10 (a) shows that Pmar3-MBP eluted at approximately 17-40% buffer B, 
which corresponds to 85-200mM imidazole. The flowthrough contained unbound, non-
specific E. coli proteins. The Pmar3-MBP-containing fractions (from 124-138ml total run 
volume) were collected, pooled together, and run through a de-salting column using 
buffer C (see Appendix C), before being incubated with 1mg TEV protease at RT for 30 
minutes, then 4oC overnight. Some Pmar3 appeared to precipitate overnight, so the lysate 
was separated from precipitants by centrifugation and was used for the reverse IMAC. A 
reverse IMAC of the lysate was carried out unsuccessfully. The SDS-PAGE gel in Figure 
2-10 (c) shows a mixed population present in the lysate of tagged and de-tagged Pmar3, 
suggesting that the TEV cleavage step needed to be optimized to increase the yield of de-
tagged Pmar3 in future purifications. A comparison of the flowthrough fractions to the 
elution fractions shows that Pmar3 did not successfully separate from non-specific 
proteins, MBP-tags, and any remaining Pmar3-MBP. The flowthrough was collected and 
pooled together to repeat the reverse IMAC with a new, smaller 1ml Ni column, and a 
shorter 15ml elution gradient. A new column was used to help increase the affinity of 
unwanted proteins to the column so Pmar3 would become better separated from 
contaminants in the flowthrough. The absorbance in the second reverse IMAC, shown in 
the chromatogram in Figure 2-10 (d), is lower than the absorbance in the first reverse 
IMAC, shown in the chromatogram in Figure 2-10 (b). This is to be expected as some 
contaminants, Pmar3-MBP, MBP-tag, and TEV protease were eluted in the first reverse 
IMAC. Figure 2-10 (e) shows that Pmar3 was mostly retained in the flowthrough. The 
elution peak contained contaminants and tagged Pmar3 that bound to the Ni column, yet 
some contaminants remained in the flowthrough. The flowthrough (1.5-16.5ml total run 
volume) was pooled together and concentrated to give a total volume of 5ml, which was 
used for size exclusion. The chromatogram for size exclusion, shown in Figure 2-10 (f), 
shows 2 major peaks with no other defined separated peaks, suggesting that Pmar3 and 
any contaminants were not able to be easily separated by size. It cannot be concluded 
which peak contained Pmar3 and if it was isolated from contaminants, as an instrument 
error occurred that caused fractions to be combined randomly. Protein analysis by SDS-
PAGE of each collection tube was carried out to check if Pmar3 was salvageable from 
any of the combined fractions. Figure 2-10 (g) shows that four fractions (lanes 8-10 and 
14) contained Pmar3 (17kDa), while some other fractions contained traces of contaminant 
bands. The four fractions that appeared to contain Pmar3 were pooled and concentrated 




The third purification of Pmar3-MBP is shown in Appendix C.  
 
 
2.3.5 Purification of Pmar4 
Soluble expression of Pmar4-His and Pmar4-MBP was unable to be achieved during 
expression trials and buffer screens, however, insoluble expression of Pmar4-His was 
achieved. An alternative approach to purifying Pmar4 was taken where I attempted to 
denature and re-fold Pmar4. Triton-X was used in a wash step to help remove the E. coli 
membrane, cell wall, inclusion bodies, and precipitants while extracting protein (Palmer 
& Wingfield, 2012). 8M urea is a common denaturant that was used to unfold Pmar4-His. 
Urea directly interacts with the peptide backbone of the protein by forming hydrogen 
bonds and creating an extended, unfolded conformation which exposes residues that 






The IMAC chromatogram shown in Figure 2-11 (b) shows that Pmar4-His eluted at 
approximately 30-90% buffer B, which corresponds to 15-45mM imidazole. This was 
confirmed by SDS-PAGE (Figure 2-11[a]), which shows that banding which likely 
corresponded to Pmar4-His at 52kDa, was consistently present throughout the elution 
gradient. The protein-containing fractions (from 70-100ml total run volume) were 
collected, pooled together, and concentrated using a 10kDa cut-off concentrator, to give 
a total volume of 5ml which was used for size exclusion. The size exclusion of Pmar4-
His showed no protein in the elution profile. This suggests that Pmar4-His did not 
completely re-fold and may have precipitated and stuck to the filter used to load the lysate 
on to the column. A native gel was run of the denatured and re-folded lysates to check 
whether the protein re-folded correctly. Figure 2-11(c) shows no clear, distinct banding 
in the “re-folded” lysate, indicating that Pmar4-His remained misfolded. This purification 
(a) 
(b) (c) 
Figure 2-11: Purification and Protein Analysis of Pmar4-His. (a) 12% SDS-PAGE gel 
of the IMAC of re-folded Pmar4-His (b) Chromatogram of the IMAC of re-folded 
Pmar4-His. (c) Native PAGE gel of the urea denatured and re-folded lysates. 
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was repeated and yielded identical results, concluding that Pmar4-His was unable to be 




2.3.6 Purification of Pmar5 
















41.85ml LBA. Sonicated: ¼”, 
Amp 2, 3min, 1s on/1s off. 
900µl buffer B added to lysate. 
Prime, 4oC 
 
1ml TEV added. 30min 
at RT then 4oC. 
overnight. 






45.7ml LBA. Sonicated: ¼”, 
Amp 3, 3min, 1s on/1s off. 1ml 
buffer B added to lysate.   
Prime, 4oC 
 
1ml TEV added. 4oC 
overnight. 























60.2ml LBA + 6µl benzonase. 




product had 1ml TEV 
added, 1hr at 37oC, 2 
days at 4oC. 
Manually run (25ml buffer C 
wash, 25ml buffer B wash) after 








54.55ml LBA. Sonicated: ¼”, 
Amp 3, 5min, 1s on/1s off. 
NGC, RT 
1ml TEV added. 1hr at 
RT, 4oC overnight.2  






   
60ml LBA. Sonicated: ¼”, 
Amp 3, 5min, 1s on/1s off. 
Prime, 4oC 
7ml size exclusion 
product had 1ml TEV 
added, 4oC overnight. 






2 De-salted lysate with buffer C containing 0.3:0.03mM glutathione redox in place of 1mM DTT. 
3 1-P5 = 0.53mg/ml, 2-P5 = 0.59mg/ml. 
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Five attempts were made at purifying Pmar5 at a large-scale, summarized in Table 2.8. 
The first purification was carried out using the same lysis and IMAC protocol that was 
used to successfully purify LigW. A 30-minute RT TEV incubation step was included, as 
this was one of the successful conditions identified when purifying Pmar3. A second 
reverse IMAC was used for this purification only, as Pmar5 appeared to non-specifically 
bind to the His-trap column. 
 
 
The cause of this remains unknown, however, a small amount of cleaved Pmar5 was 
obtained from the second reverse IMAC (Figure 2-12). Despite an unsuccessful size 
exclusion (shown in Appendix C), the highlighted band in lane 5 of Figure 2-12 (b) was 
confirmed to be Pmar5 by carrying out liquid chromatography-mass spectrometry. The 
spectra data obtained for the protein band matched the amino acid sequence for Pmar5 
and some minor E. coli proteins of similar molecular weight. Given this confirmation, 
further attempts were made to purify Pmar5 from a Pmar5-MBP culture.  
 
Adjustments were made to the purification protocol to overcome low rates of MBP-tag 
cleavage, low yield of de-tagged Pmar5, and to address a consistent issue where a mixed 
population of Pmar5-MBP and Pmar5 was obtained after reverse IMAC and size 
exclusion. The second purification was not continued beyond the reverse IMAC as the 
protein had de-stabilized and crashed overnight when incubated with TEV protease at 
4oC.  
(a)       (b) 
Figure 2-12: First Purification and Protein Analysis of Pmar5-MBP. (a) Chromatogram 
of the second reverse IMAC of Pmar5-MBP. (b) 12% SDS-PAGE gel of the second 





Figure 2-13: Third IMAC Purification and Protein Analysis of Pmar5-MBP. (a) Chromatogram 
of the IMAC of Pmar5-MBP. (b) 12% SDS-PAGE gel of the IMAC. (c) Chromatogram of the 
size exclusion of Pmar5-MBP. (d) 12% SDS-PAGE gel of the size exclusion. Peak 1 shows bands 
corresponding to Pmar5-MBP (68kDa) and Pmar5 (23kDa). 
 
The third purification was carried out at RT to test whether the stability of Pmar5 was 
affected by temperature. Benzonase was added during the lysis step to help degrade 
contaminating DNA. Pmar5 remained stable when purified at RT and did not precipitate 
when incubated with TEV protease at RT for 1 hour, followed by 4oC overnight. The 
SDS-PAGE gel of the first IMAC shown in Figure 2-13 (b) showed that Pmar5-MBP 
appeared to separate from the majority of non-specific E. coli proteins during the first 
step, so the cleaved sample was concentrated for size exclusion. The chromatogram 
shown in Figure 2-13 (c) and the SDS-PAGE gel in Figure 2-13. (d) shows that Pmar5 
was successfully separated from contaminant proteins. However, Pmar5 was unable to be 
separated from Pmar5-MBP by size exclusion. I began to suspect that the de-tagged 
Pmar5 may have continued to interact with Pmar5-MBP in a way that could not be 
disrupted. I hypothesised that Pmar5 could be a multimeric protein, and the MBP-tag was 
not fully cleaved from all sub-units.  
 
(a)           (b) 
(c)           (d) 
 
58 
The fourth purification was carried out using an alternative buffer C which contained a 
glutathione redox (0.3mM reduced glutathione to oxidized glutathione) in place of the 
reducing agent DTT. This buffer was trialled to assist with MBP-tag cleavage, as TEV is 
a cysteine protease that requires a reducing agent to achieve high activity. Pmar5 contains 
7 cysteine residues and is predicted to have up to three disulphide bonds form between 
the thiol groups of cysteine residues to stabilize the protein structure. Pmar5-MBP had 
aggregated during some purifications, which was potentially caused by breaking 
disulphide bonds that were essential for protein stability. The glutathione redox buffer 
was proposed as a suitable alternative that would still allow TEV protease to function. 
  
 
Although Pmar5-MBP did not precipitate overnight, the SDS-PAGE gel of the reverse 
IMAC (Figure 2-14) shows that Pmar5-MBP was not successfully cleaved. This suggests 
that TEV protease activity was not sufficiently stimulated by the glutathione redox, so 
buffer C containing DTT continued to be used in future purifications. 




The fifth purification of Pmar5-MBP resulted in the isolation of Pmar5 from Pmar5-MBP. 
In summary, the IMAC chromatogram shown in Figure 2-15 (a) and the SDS-PAGE gel 
shown in Figure 2-15 (b) shows that Pmar5-MBP eluted at approximately 48-68% buffer 
B, which corresponds to 240-340mM imidazole. The flowthrough and first 48% of the 
buffer B gradient contained unbound, non-specific proteins, which continued to be 
removed with each step of the purification method. The protein-containing fractions 
(a)         (b) 
(c)         (d) 
(e) 
Figure 2-15: Fifth IMAC purification and protein analysis of Pmar5. (a) Chromatogram 
from IMAC of Pmar5 showing the UV absorbance (280nm) and elution of Pmar5-MBP 
at 48-68% buffer B. (b) 12% SDS-PAGE gel showing a high yield of Pmar5-MBP and 
removal of non-specific proteins in the IMAC elution peak. (c) Chromatogram from the 
size exclusion of Pmar5-MBP, showing the UV absorbance (280nm) of Pmar5-MBP 
between 49-59 run volume. (d) Chromatogram of the reverse IMAC showing the UV 
absorbance of Pmar5 in the flowthrough, and the MBP-tag, Pmar5-MBP and other 
contaminating proteins in the elution peak. (e) 12% SDS-PAGE gel showing the 




(from 104-114ml total run volume) were collected, pooled together, and concentrated to 
a final volume of 4ml for size exclusion. Figure 2-15 (b and c) shows that Pmar5-MBP 
(peak 2) was successfully separated from non-specific proteins (peak 1). Peak 2 (49-59ml 
total run volume) was pooled together, and 7ml was incubated with 1mg TEV protease at 
4oC overnight, while the remaining 3ml was stored in 100µl aliquots at a final 
concentration of 6.06mg/ml for future use in assays. The incubated lysate was run through 
a reverse IMAC. The chromatogram shown in Figure 2-15 (d) and the SDS-PAGE gel in 
Figure 2-15 (e) shows that Pmar5 (23kDa) was successfully isolated in the flowthrough 
from Pmar5-MBP (68kDa) in the elution peak. The shoulder of the elution peak appeared 
to contain most of the cleaved Pmar5, so these fractions and the flowthrough were pooled 
together and concentrated in two batches to final concentrations of 0.53mg/ml (1-P5) and 




LigW, Pmar3, and Pmar5 can be successfully expressed and purified using the methods 
that were optimized and outlined in this chapter. Pmar5 remains challenging to purify, as 
the MBP-tagged and de-tagged protein appear to interact and remain as a mixed 
population during purifications, suggesting that Pmar5 may be a multimeric protein. A 
low yield of de-tagged Pmar5 is attainable, but further optimization is required to obtain 
a higher concentration of Pmar5. Soluble expression and purification of Pmar4 remains 
to be achieved. Insoluble expression of Pmar4 was consistently achieved in a pDEST17 
expression vector, however, no expression was observed in a pHMGWA expression 
vector.  
 
Sufficient yields of LigW, Pmar3, and Pmar5 were obtained for characterization, 
however, further optimization is required for Pmar4. The next chapter summarizes the 
steps that were taken to characterize Pmar3 and Pmar5 as individual proteins, and their 
ability to enhance LigW activity was explored.  
 
2.5 Future Research 
The expression of Pmar4 will be continued to be tested and optimized to ideally achieve 
soluble expression. Pmar4 will be transformed into a pDEST15 expression vector which 
has a glutathione S-transferase tag that assists with the expression and purification of 
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proteins (Francis & Page, 2010). Although an MBP-tag should assist with soluble 
expression (as seen with Pmar3 and Pmar5) no expression of Pmar4-MBP was observed. 
The His-tag appeared to allow expression of Pmar4, so a His-tag will be placed on the C-
terminus in an attempt to improve soluble expression. Pmar3 and Pmar5 will have spacers 
introduced between the protein and TEV binding site to help increase TEV cleavage 
efficiency and increase the yield of de-tagged protein, which will be used for 
crystallization trials.  
 
We suspect that Pmar3-mut may have been present in the insoluble pellets of the 
expression trial. Further expression trials of Pmar3-mut will be carried out using DNase 
to degrade contaminating DNA and improve gel samples, to identify favourable 
expression conditions, and to clarify whether Pmar3-mut showed insoluble expression. If 
expression is not achieved, Pmar3-mut will be transformed into pDEST15 and pDEST17 
expression vectors and further expression trials will be carried out. Alternatively, a new 
mutant may be created with one aspartate to alanine point mutation, as the stability of 







Although hypothesised as DNA-modifying proteins, the exact function of Pmar3, Pmar4, 
and Pmar5 needed to be determined. Biochemical characterization of proteins involves a 
series of activity assays that are necessary to determine how each protein functions under 
different conditions and in response to different substrates. In addition to determining the 
molecular weight and thermal stability of Pmar3 and Pmar5, each protein’s ability to bind 
damaged DNA and each protein’s interactions with LigW were explored through gel-
based assays. 
 
Electrophoretic mobility shift assays were used to assess each protein’s ability to 
recognize and bind to different length DNA substrates. Successful binding to a substrate 
would create larger protein-DNA complexes that can be observed as a gel-shift on 
electrophoresed native TBE gels. Nuclease activity was assessed using a fluorescence 
nuclease assay, where nucleases would bind to and degrade DNA substrates of different 
lengths. Degradation of DNA was also visualized as a gel-shift on electrophoresed native 
TBE gels. Native TBE gels show the native conformation of the DNA, allowing 
differentiation between structurally conserved double-stranded and single-stranded 
products. Nuclease assay samples were treated with proteinase K to digest the protein by 
hydrolysing the peptide bonds, allowing visualization of only the DNA. The substrates 
were labelled with 5-carboxyfluorescein (5-FAM) labels to allow visualization of 
products on the gels and to quantify the fluorescence of different-sized products 
(Williamson et al., 2014).  
 
At the commencement of this research, Pmar5 had been annotated as a predicted 
topoisomerase. Topoisomerases are enzymes capable of overwinding or unwinding DNA 
to relieve supercoiling during DNA replication and repair (Champoux, 2001). The 
potential topoisomerase activity of both Pmar3 and Pmar5 was explored by incubating 
each protein with a supercoiled, circular, double-stranded pUC19 plasmid. Unlike the gel-
shift assays, the product of topoisomerase assays does not change composition, and 
instead, a change in the topology of pUC19 is to be expected. There are multiple classes 
of topoisomerase that introduce single-strand or double-strand cuts in the DNA, which 
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can be visualized as different sized bands on a 1% TAE agarose gel with lower linking 
numbers (i.e. less supercoiling) in the plasmid running with greater apparent size 
(Champoux, 2001; Terekhova et al., 2012). The assay reactions were proteinase K treated 
similarly to the nuclease assay.  
 
The characterization of Pmar3 and Pmar5 entails determining each protein’s role in the 
LigW operon. Both proteins are adjacent to LigW and are hypothesised to enhance 
LigW’s poor ligation activity (Williamson, Unpublished). Each protein was incubated 
with LigW and a 5-FAM labelled nicked DNA substrate to see if and to what extent the 
single-stranded breaks were being sealed. Reactions were visualized on 7M urea gels, 
which denature proteins and DNA, allowing visualization of only the 5-FAM labelled 
single strand. Single nucleotide differences such as sealed nicks can be seen on a urea gel 
as distinct different-sized bands (Summer et al., 2009). 
 
This chapter focuses on the biochemical characterization of Pmar3 and Pmar5.  
 
 
3.2 Materials and Methods 
3.2.1 Analytical Size Exclusion 
The ENrich 650 analytical gel filtration column (Bio-Rad Laboratories, USA) was 
calibrated to determine the buffer-specific molecular weights and column void volume, 
according to the manufacturer’s instructions. In summary, the column was equilibrated 
with 2 column volumes of buffer C before loading 250µl Bio-Rad size-exclusion 
standards (catalogue #151-1901) or blue dextran respectively, followed by 1 column 
volume of buffer C. The molecular weight of proteins was determined by loading 200-
500µl concentrated protein onto the pre-equilibrated column. The sample was loaded onto 
the column by manual injection using a syringe. The column was run with 1 column 
volume of buffer C at 1ml min-1. Eluted protein fractions were collected and analysed on 
SDS-PAGE. The elution volumes (Ve) of the standards, the column void volume (Vo), 
and the total column volume (Vc) were used to calculate the gel phase distribution 










Calibration standard curves of Kav relative to molecular weight were made. Protein 
elution volumes were plotted against the calibration standard curves to determine the 
molecular weight of each protein, shown in Equation 3-2. 
 
Equation 3-2: Formula for calculating the molecular weight. 




3.2.2 Thermal-Shift Assay 
The melting temperature and pH stability of proteins were determined by performing a 
thermal-shift assay. 25µl reactions involving varying concentrations of protein, 3µl 5X 
SYPRO, and 14µl Britten Robinson Universal Buffer (40mM H3BO3, 40mM H3PO4, 
40mM CH3COOH, pH 5.0-9.0) were set up in PCR tubes at RT. PCR tubes were loaded 
into the Corbett Rotor-GeneTM 6000, and rotor-gene Q series software was used to run 
and analyse a melt from 25oC-99oC.  
 
3.2.3 Electrophoretic Gel Mobility Shift Assay 
Electrophoretic gel mobility shift assays were used to assess each protein’s ability to bind 
to damaged DNA. 20µM of Pmar3, Pmar5, or LigW was incubated with 80nM DNA 
substrate (see Table 3.2 and Table 3.3) at 15oC for 30 minutes. Reaction compositions are 
summarized in Appendix D. 5µl loading dye (100mM EDTA, 0.25% bromophenol blue, 
25% v/v glycerol) was added to each reaction, and 10µl was loaded and run on 10x native 
TBE gels (cast using a Hoeffer five gel multi-gel caster, see Table 3.1) at 5mA per gel 
using 1x TBE buffer (90mM tris-base, 90mM boric acid, 2mM EDTA). Gels were imaged 
using an iBright imager (Invitrogen).  
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Table 3.1 Recipe for 10x Native TBE Gels 





10x TBE Buffer4 1ml 
10% APS 100µl 
TEMED 3µl 
  
Table 3.2: Sequences of the oligonucleotides used to make electrophoretic mobility shift assay 
substrates. 
Description Oligonucleotide sequence (5’ to 3’) Modification 
Nick FAM 5’-AGGCCATGGCTGATATCGCA-3’ 5’ FAM 









Blunt Complement 5’-CGACGGAGCTCGAATGCCTA-3’ - 
 










Linear Nick Complement - 
Single-strand Linear - - 
3’-Tail Linear Blunt Complement - 
5’-Tail Nick FAM Nick Complement - 
Nick Nick FAM Nick Complement Nick Phos 
 
3.2.4 Topoisomerase Assay 
Topoisomerase activity of Pmar3, Pmar5, and LigW was assessed by incubating each 
protein with a pUC19 plasmid. pUC19 purified from E. coli exists in a supercoiled 
conformation and can be relaxed by topoisomerases to give a relaxed circular product, or 
 
4 Tris-borate-EDTA buffer. 108g Tris-base, 55g boric acid, 7.5g EDTA, ddH2O to 1L. 
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cuts can be made by nucleases. pUC19 was prepared using a QIAprep® Spin Miniprep 
Kit (Bio-strategy) according to the manufacturer’s instructions. 5µl of proteins of varying 
concentrations were incubated at RT with 2µl pUC19 (81.2-98.6 ng/µl) in PCR tubes for 
time periods of 30 minutes to 18 hours. Metal-dependency and substrate-dependency for 
topoisomerase activity was measured by adding 5mM MgCl2, 5mM MnCl2, 10mM ZnCl2, 
1mM ATP, or 1mM GTP to reactions. 2µl proteinase K was added to each reaction and 
incubated at 37oC for 1 hour. The reaction was stopped by adding 2.5µl 10x 
topoisomerase stop buffer (100mM EDTA, 0.25% bromophenol blue, 25% v/v glycerol). 
1% agarose gels were used to degrade the protein, which revealed any changes in pUC19 
supercoiling. 
 
1% agarose gels were made and run according to section 2.2.3, but without the addition 
of SYBR-safe during casting. Gels were post-stained for 20 minutes in 100ml 1xTAE and 
10µl thiazole orange was added. A post-stain was performed instead of adding thiazole 
orange to the agarose gel to preserve any supercoiled topology. Thiazole orange inter-
chelates with bases and causes supercoiled pUC19 to appear the same as pUC19 with a 
relaxed topology. Agarose gels were imaged using an iBright Imager (Invitrogen). 
 
3.2.5 Fluorescence Nuclease Assay 
Fluorescence-based nuclease assays were used to assess the nuclease activity of Pmar3. 
2.5µl of Pmar3 of varying concentrations was incubated with one of six 80nM DNA 
substrates (see Table 3.4 and Table 3.5) at RT for time periods of 30 minutes to 17 hours. 
Reaction compositions are summarized in Appendix D. 2µl proteinase K was added to 
each reaction and incubated at 37oC for 1 hour. The reaction was stopped by adding 2.5µl 
nuclease stop buffer (100mM EDTA, 0.25% bromophenol blue, 25% v/v glycerol). 10µl 
was loaded and run on 10x native TBE gels at 5mA per gel using 1x TBE buffer. Gels 
were imaged using an iBright Imager (Invitrogen).  
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Table 3.4: Sequences of the oligonucleotides used to make fluorescence nuclease assay substrates. 
Description Oligonucleotide sequence (5’ to 3’) Modification 









Blunt Complement 5’-CGACGGAGCTCGAATGCCTA-3’ - 
 
Table 3.5: Oligonucleotide components annealed to make fluorescence nuclease assay substrates. 
Substrate FAM-labelled Oligo Complement 
Double-strand Matched Linear Nick Complement 
Single-strand Linear - 
3’-Tail Linear Blunt Complement 
5’-Tail Nick FAM Nick Complement 
20+20 Control Nick FAM Blunt Complement 
Single-strand (20) Control Nick FAM - 
 
3.2.6 Coupled Ligation Assay 
Coupled assays of Pmar3 and Pmar5 with LigW were conducted to observe the effect that 
each protein has on the ligation activity of LigW. Varying concentrations of protein were 
incubated for 1 hour at 25oC with a constant concentration of 5µM LigW and nicked DNA 
master mix (80nM DNA substrate, 1mM ATP, 50mM NaCl, 50mM tris pH 8.0, 1mM 
DTT). Reactions were quenched with 5µl quench buffer (95% formamide, 1% EDTA, 
1% bromophenol blue) and further incubated for 5 minutes at 95oC. 7M urea PAGE gels 
(cast using a Hoeffer five gel multi-gel caster, see Table 4.4) were pre-run for 30 minutes 
at 5mA per gel at 47oC with 1xTBE buffer. 10µl samples were loaded onto pre-run 7M 
urea PAGE gels and were ran at 5mA for approximately 1.5hrs. Gels were visualised 





Table 3.6 Recipe for 7M Urea Gels 
 1 Gel 
20% Acrylamide/7M Urea 10ml 




3.3 Results and Discussion 
3.3.1 Analytical Size Exclusion 
 
The molecular weight of Pmar5-MBP in glutathione redox buffer (500mM tris pH 8.0, 
100mM NaCl, 5% glycerol, 0.5mM EDTA, 0.3:0.03mM glutathione redox) was 
determined using analytical size exclusion (shown in Figure 3-1). A calibration curve 
(Figure 3-1 [d]) was plotted based on the elution volumes and corresponding Kav values, 
summarized in Table 3.7.  
Figure 3-1: Determination of the molecular weight of Pmar5-MBP. (a) Chromatogram 
for blue dextran to determine the void volume of the ENrich 650 analytical gel filtration 
column (Bio-Rad Laboratories, USA). (b) Chromatogram for Bio-Rad size-exclusion 
standards (catalogue #151-1901) to determine the gel phase distribution coefficient (Kav). 
(c) Chromatogram for the size exclusion of Pmar5-MBP. (d) Calculated calibration curve 
of molecular weight against Kav. The Kav of Pmar5-MBP (red) was plotted and used to 
determine the molecular weight of Pmar5-MBP. 








(c)           (d) 
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Table 3.7: Bio-Rad size-exclusion standards (catalogue #151-1901) and the corresponding 
elution volumes (Ve) and Kav values when using glutathione redox buffer. 
Protein Molecular Weight (Da) Elution Volume (ml) Kav 
Vitamin B12 1350 18.35 0.59 
Myoglobin 17000 15.83 0.41 
Ovalbumin 44000 14.5 0.31 
γ-globulin 158000 12.59 0.17 
Thyroglobulin 670000 10.45 0.02 
 
Figure 3-1 (c) shows that Pmar5-MBP eluted at 11.46ml, with a Kav of 0.09. The 
molecular weight of Pmar5-MBP (calculated using Equation 3-2) is equal to 379.6kDa. 
According to the sequence of Pmar5-MBP, the molecular weight is predicted to be 
approximately 67.8kDa. Based on the analytical SEC results, Pmar5-MBP is predicted to 
be a pentameric protein, as the molecular weight was calculated to be approximately 5 
times larger than the sequence-predicted molecular weight. The multimeric nature of 
Pmar5-MBP could account for the difficulties encountered when attempting to de-tag 
Pmar5 and when separating the mixed population of tagged and de-tagged Pmar5 by size 
exclusion. If Pmar5 is a multimeric protein, the MBP-tag may be difficult to cleave 
successfully from all the domains. The calculated molecular weight is more than 5 times 
larger than predicted, which also suggests that the protein may be asymmetric with a 
larger Stokes radius than a sphere of the same molecular weight, causing it to elute earlier 
on the column (Burgess, 2018). The molecular weight and multimeric nature of Pmar5 
could be confirmed in the future by running de-tagged Pmar5 through analytical size 
exclusion, as well as attempting crystallography to solve the protein’s structure.  
 
The molecular weight of Pmar3 in buffer C (50mM tris pH 8.0, 100mM NaCl, 5% 
glycerol, 1mM DTT, 0.5mM EDTA) was attempted to be determined using analytical 
size exclusion (shown in Figure 3-2 [c]). A calibration curve (Figure 3-2 [a]) was plotted 




Table 3.8: Bio-Rad size-exclusion standards (catalogue #151-1901) and the corresponding 
elution volumes (Ve) and Kav values when using buffer C. 
Protein Molecular Weight (Da) Elution Volume (ml) Kav 
Vitamin B12 1350 18.58 0.62 
Myoglobin 17000 16.04 0.44 
Ovalbumin 44000 14.61 0.34 
γ-globulin 158000 12.75 0.21 
Thyroglobulin 670000 10.54 0.05 
 
Figure 3-2 (b) shows that Pmar3 eluted at 17.03ml, with a Kav of 0.51. The molecular 
weight of Pmar3 (calculated using Equation 3-2) is equal to 5.5kDa. According to the 
sequence of Pmar3, the molecular weight is predicted to be approximately 17.0kDa and 
was expected to elute at approximately 16ml. Based on the analytical SEC results, Pmar3 
is predicted but cannot be accurately concluded, to be a monomer. The calculated 
Figure 3-2: Determination of the molecular weight of Pmar3. (a) Calculated calibration 
curve of molecular weight against Kav. The Kav of Pmar3 (red) was plotted and used to 
determine the molecular weight of Pmar3. (b) Chromatogram for the size exclusion of 
Pmar3. (c) 12% SDS-PAGE gel for collected fractions from size exclusion of Pmar3. 
Pmar3 was present in peak 1 (indicated by the white arrow).  
(a) 
(b)            (c) 
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molecular weight from analytical SEC is less than the sequence-predicted molecular 
weight. Pmar3 may be asymmetrical, but in contrast to Pmar5-MBP, it may have a smaller 
Stokes radius than a sphere of the same molecular weight, causing it to elute later on the 
column. Alternatively, Pmar3 could have interacted with the resin or column tube, 
interfering with its movement down the column and also causing it to elute later (Burgess, 
2018). The molecular weight of Pmar3 could be confirmed in the future by running a 
native PAGE gel, as this would allow us to visualize its size and native structure. Attempts 
could also be made to crystallize Pmar3 to solve the protein’s structure. 
 
3.3.2 Thermal-Shift Assays 
Thermal-shift assays were run of all three proteins of interest over a pH scale of 5.0-9.5, 
and a temperature range of 25-99oC. The purpose of these assays was to identify the 
melting temperatures (Tm) of each protein and the pH that promoted protein stability. 
Fluorescence of Sypro was used to detect the protein states: folded, unfolded, or 
aggregated. An increase in fluorescence is observed upon denaturation when SYPRO 
Orange binds to the protein’s exposed hydrophobic groups. Fluorescence decreases as the 
protein aggregates with increasing temperature (Bai et al., 2019).  
 
 
A thermal-shift assay (Figure 3-3) was run of three samples of a final concentration of 
17.4µM Pmar3 (Purification 2). Varying concentrations of Sypro tested for optimal 
fluorescence detection as the protein unfolded. The 6µl Sypro sample was excluded from 
analysis, as the maximum detectable fluorescence on the instrument was exceeded. Figure 
Figure 3-3: Thermal-shift assay of 17.40µM Pmar3. Reaction compositions: 17.40µM 
Pmar3 (19µl), Sypro + buffer C (6µl). (a) Chromatogram showing a thermal-shift assay 
of Pmar3 from 25-99oC. (b) First derivatives of assay data to determine the Tm of Pmar3. 
Arrows point to the maximum point of each curve. 3µl Sypro sample Tm = 42.7oC, 1.5µl 
Sypro sample Tm = 44.3oC.  
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3-3 (b) shows the first derivative calculations for the remaining two samples. The 
maximum points of the first derivative curves correspond to the Tm of the samples. The 
3µl Sypro sample had a Tm of 42.7
oC, while the 1.5µl Sypro sample had a Tm of 44.3
oC. 
An additional thermal-shift assay was completed of Pmar3 across the pH scale (5.0-9.5) 
to confirm the Tm and preferred pH that promotes protein stability. 
 
 
Figure 3-4 shows that Pmar3 has a Tm range of approximately 41-44
oC and no conclusive 
pH that provides protein stability. The findings from this assay were used to help select 




Figure 3-4: Thermal-shift assay of 35.13µM Pmar3 from 25-99oC in Britten Robinson 
universal buffer (40mM H3BO3, 40mM H3PO4, 40mM CH3COOH, pH 5.0-9.5). Reaction 
compositions: 35.13µM Pmar3 (8µl), Sypro (3µl) + pH buffer (14µl). (a) Chromatogram 
showing a thermal-shift assay of Pmar3 from 25-99oC. (b) First derivatives of assay data 




Figure 3-5: Chromatogram showing a thermal-shift assay of Pmar4-His from 25-99oC in Britten 
Robinson universal buffer (40mM H3BO3, 40mM H3PO4, 40mM CH3COOH, pH 5.0-9.0). 
 
A thermal-shift assay was run of Pmar4-His in addition to the native PAGE gels after 
attempting an IMAC purification, to confirm whether Pmar4-His had re-folded correctly. 
Figure 3-5 shows that the reactions containing Pmar4-His fluoresced before any heat 
treatment. This confirms that Pmar4-His did not re-fold correctly, as fluorescence is 
observed upon denaturation when SYPRO Orange binds to the protein’s exposed 
hydrophobic groups (Bai et al., 2019). As discussed in the previous chapter, further 
optimization of soluble expression or protein re-folding is required to characterize Pmar4. 
 
The thermal-shift assays were conducted with 13.64 and 7.27µM Pmar5 to determine the 





A low protein concentration was used comparatively to Pmar3, which introduced some 
background noise in the data, which is particularly obvious in the second derivative 





Figure 3-6: Thermal-shift assays of Pmar5. (a, b) Reaction compositions: 13.64µM Pmar5 
(15µl), Sypro + buffer C (10µl). (a) Chromatogram showing a thermal-shift assay of 
Pmar5 from 25-99oC. (b) First derivatives of assay data to determine the Tm of Pmar5. 
Arrows point to the maximum point of each curve. 6µl Sypro sample Tm = 47.6oC, 3µl 
Sypro sample Tm = 48.4oC, 1.5µl Sypro sample Tm = 48.4oC. (c-e) Reaction compositions: 
7.27µM Pmar3 (8µl), Sypro (3µl) + pH buffer (14µl). 25-99oC in Britten Robinson 
universal buffer (40mM H3BO3, 40mM H3PO4, 40mM CH3COOH, pH 5.0-9.5). (c) 
Chromatogram showing a thermal-shift assay of Pmar5 from 25-99oC. (b) First 




almost 8 °C with increasing pH. Buffer C has a pH of 7, which explains why a Tm of 
approximately 48oC was observed in Figure 3-6 (a and b).   
 
3.3.3 Electrophoretic Mobility Shift Assays 
Table 3.9: Diagrams of the substrates used in electrophoretic mobility shift assays. 












Protein-nucleic acid interactions were assessed through electrophoretic mobility shift 
assays (EMSA), where each protein’s ability to bind to damaged DNA was tested using 
double-stranded matched, single-stranded, 3’ tail, 5’ tail, and nicked substrates (see Table 
3.9). These assays were selected as Pmar3 and Pmar5 were hypothesised to be DNA-
modifying proteins, and we wanted to investigate if either of these proteins had an affinity 
for different types of damage. A variety of substrates were used to help predict the 




















Figure 3-7: Native 10% TBE gel of the Electrophoretic Mobility Shift Assay of 20µM LigW. 
 
LigW was used as a positive control to test whether the conditions were suitable to show 
DNA binding. Ligases are expected to recognize and bind to nicked DNA, so a gel shift 
of the nicked substrate should be observed. A gel shift in lane 10 of Figure 3-7 shows that 
LigW successfully bound to the nicked substrate, indicating that LigW recognizes nicked 






Unlike LigW, Figure 3-8 shows that Pmar3 and Pmar5 did not bind to any of the 
substrates used. It is likely that both Pmar3 and Pmar5 do not recognize or prefer the 
substrates tested. Although the proteins did not bind, it is suspected that the proteins can 
recognize other sequences of DNA or other types of damage. It is also possible that the 
proposed DNA-binding activity of Pmar3 and Pmar5 may be dependent on metals or other 
additives that were omitted from this assay. Pmar3 and Pmar5 may have weak binding 
activity, which can be explored in the future by repeating this assay with a higher 
concentration of protein compared to DNA substrate (Hellman & Fried, 2007). The 
potential functions of Pmar3 and Pmar5 were further explored through a series of nuclease 
and topoisomerase assays, which confirmed that protein inactivity was not the cause for 
the lack of substrate binding.  
 
3.3.4 Assessing Topoisomerase Activity of Pmar3 
Although hypothesised to be a DNA-modifying protein, the function of Pmar3 remained 
to be determined through a series of activity assays. Determination of the function of 
Pmar3 began by assessing its ability to act as a topoisomerase, where it would relieve the 
supercoiling of a pUC19 plasmid.  
Figure 3-8: Native 10% TBE gel of the Electrophoretic Mobility Shift Assay of 




Firstly, metal dependency was investigated by incubating Pmar3 and pUC19 with Mg, 
Mn, and Zn. Mg and Zn have been required for DNA relaxation in different classes of 
topoisomerase (Champoux, 2001), and were therefore predicted to be essential for Pmar3 
activity. Figure 3-9 shows that Pmar3 did not appear to interact with pUC19. There was 
no increase in size consistent with topoisomerase activity; however complete degradation 
was observed with Pmar3 + Mg, which was far greater than the control which had a 
mixture of supercoiled and nicked plasmid. There was no change in the apparent size of 
the bands observed in the Zn-containing reactions, indicating that Pmar3 does not rely on 
Figure 3-9: 1% TAE agarose gel of a topoisomerase assay where 2.29µM Pmar3 was 
incubated with 162.4ng pUC19 for 18 hours. Metal-dependent activity was investigated 
by incubating Pmar3 and pUC19 with 5mM MgCl2, 5mM MnCl2 or 10mM ZnCl2. BamHI 
was included as a restriction enzyme control to show the difference in apparent size  when 
pUC19 is cut. 
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Zn to be active. The Mn control showed complete degradation of pUC19 without Pmar3 
present, so no conclusions could be drawn on the activity of Pmar3 and Mn with plasmid 
DNA. Mg alone appeared to cut pUC19 without Pmar3 present, shown by a difference in 
apparent band size in lane 2. This was later attributed to the homemade topoisomerase 
buffer containing low-grade Bovine Serum Albumin (BSA), which was omitted from the 
buffer used in the assays assessing the topoisomerase activity of Pmar5. The degradation 
of pUC19 suggests that Pmar3 could be displaying nuclease activity.  
 
 
A second assay, shown in Figure 3-10, was run for a shorter time of 2 hours to see if the 
supercoiling of pUC19 was being relaxed by Pmar3. 5mM MgCl2 was included as a co-
factor as it appeared to promote Pmar3 activity in the initial assay. Three dilutions of 
Figure 3-10: 1% TAE agarose gel of a topoisomerase assay where a dilution series of 
2.29µM (1x), 0.46µM (5x dilution), and 0.23µM (10x dilution) Pmar3 was incubated with 
162.4ng pUC19 and 5mM MgCl2 for 2 hours. Pmar3 was incubated with the restriction 




Pmar3: 2.29µM (1x), 0.46µM (5x dilution), and 0.23µM (10x dilution), were incubated 
with pUC19 to observe how the topology of pUC19 changed with different concentrations 
of Pmar3. The ratio of cut pUC19 to supercoiled pUC19 appeared to decrease with 
decreasing Pmar3 concentration, suggesting that higher concentrations of Pmar3 are 
required to relieve supercoiling. Pmar3 was incubated with BamHI, a restriction enzyme, 
to check if Pmar3 was displaying exonuclease activity. There was no shift in banding 
compared to the BamHI control reaction, allowing us to conclude that Pmar3 is not an 
exonuclease.  The Pmar3 containing reactions have banding at the bottom of the agarose 
gel, which shows that pUC19 has continued to be degraded by Pmar3.  
 
It was concluded that Pmar3 is unlikely to be a topoisomerase, as it appears to be the 
cutting pUC19 plasmid instead of relaxing the supercoiling. The degradation of pUC19 
observed in these assays led to the hypothesis that Pmar3 may be a nuclease. The potential 
nuclease activity of Pmar3 was investigated through a series of fluorescence nuclease 
assays. 
 
3.3.5 Assessing Nuclease Activity of Pmar3 
 
Table 3.10: Diagrams of the substrates used in fluorescence nuclease assays. 

































The nuclease activity of Pmar3 was assessed through a series of fluorescence nuclease 
assays, where the affinity to and degradation of double-stranded matched, single-
stranded, 3’ tail, and 5’ tail substrates (see Table 3.10) by Pmar3 was explored. Pmar3 
appeared to degrade the supercoiled pUC19 plasmid and was hypothesised to also be 
capable of degrading other nucleotide sequences. 
 
 
An initial assessment of potential nuclease activity was made by incubating Pmar3 with 
the substrates overnight (19 hours) in duplicates. The first six lanes of Figure 3-11 show 
the expected size of the substrates without any nuclease activity, and include 20nt double-
stranded and single-stranded controls in lanes 5 and 6 respectively. Pmar3 successfully 
and consistently degraded all the tested substrates, further suggesting that Pmar3 could 
function as a nuclease. The batch of Pmar3 used in this assay (purification 2) was of low 
concentration, so this assay was repeated with a 6-hour incubation period, using two 
higher concentration purified batches of Pmar3 (purification 3) to check for consistent 
nuclease activity.  
 
Figure 3-11: 10x Native TBE gel of a fluorescence nuclease assay. 2.29µm Pmar3 was 
incubated overnight with double-strand matched, single-strand, 3' tail and 5' tail 5'-FAM 




The substrates were all consistently degraded by different batches of Pmar3, (shown in 
Figure 3-12) which further suggests that Pmar3 may be a nuclease. The ds-matched 
substrate was not completely degraded by the lower concentration (11.0µM) batch but 
was completely degraded by the higher concentration (29.3µM) batch of Pmar3.  
Figure 3-12: 10x Native TBE gels of 6-hour fluorescence 
nuclease assays comparing the two batches of Pmar3 from 









Figure 3-13: 10x Native TBE gels of fluorescence nuclease assays of Pmar3. 2.29µm Pmar3 
was incubated with double-strand matched, single-strand, 3' tail and 5' tail 5'-FAM 




The nuclease substrates appeared to be completely degraded when incubated overnight 
with Pmar3 (purification 2), and for 6 hours with higher concentration Pmar3 
(purification 3). The affinity of Pmar3 to different substrates was investigated by 
observing the changes in the degradation of substrates over different time periods. Figure 
3-13 shows the native TBE gels for fluorescence nuclease assay reactions that were 
incubated for 1, 2, and 4 hours. An increase in degradation over time was observed for all 
four substrates. Pmar3 appeared to have an affinity for the 5’ tail substrate, as this was 
almost completely degraded after 1 hour of incubation. In contrast, Pmar3 appears to act 
slower on the ds-matched substrate. Different sized product bands can be observed in the 
ss and 3’-tail substrate samples in Figure 3-13 (b) which corresponds to both 20 and 40nt 
products. The affinity towards the ss-matched substrate seen in Figure 3-12 was 
confirmed by performing a 6-hour assay of a dilution series of Pmar3 incubated with the 
ds-matched and ss-matched substrates (Figure 3-14).  
 
 
Figure 3-14: 10x Native TBE gel of a 6-hour fluorescence nuclease 
assay of Pmar3. A dilution series was performed with 1x, 1/5, 1/10 and 
1/20 dilutions of 1-P3 (29.3, 5.9, 2.9, 1.5µM).  
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It was concluded that Pmar3 shows consistent nuclease-like activity. However, nucleases 
can be difficult to remove from the solution during purifications. To further prove that 
Pmar3 may be a nuclease, Pmar3 (purification 2) was deactivated and then incubated with 
the nuclease substrates for 8 hours parallel to active Pmar3. The thermal-shift assay 
results for Pmar3 indicated that heating Pmar3 above its melting temperature of 41-44oC 
would deactivate the protein. To ensure deactivation, Pmar3 was heated at 55oC. Parallel 
assays were completed and compared to observe if any residual nucleases in solution may 
be responsible for the observed nuclease activity in previous assays. 
 
 
Figure 3-15 shows a decrease in nuclease activity in the deactivated Pmar3 reactions 
compared to the active Pmar3 containing reactions. Although the substrates appear to still 
be slightly degraded in Figure 3-15 (b), the decreased nuclease-like activity upon 
deactivation shows that Pmar3 is likely to be a nuclease. The trace activity observed could 
be because not all the Pmar3 was unfolded at 55oC, or Pmar3 potentially re-folded after 
heating. In the future, a higher melting temperature could be used to increase the 
successful deactivation of Pmar3.  
 
Observed nuclease activity could be due to residual contaminants that could not be 
removed during IMAC purification. To exclude this possibility, a mutant of Pmar3 was 
designed with four point-mutations of aspartate to alanine (positions 46, 75, 78, and 140), 
which removes the acidic residues that are often conserved in the catalytic domain, and 
(a) (b) 
Figure 3-15: 10x Native TBE gels of fluorescence nuclease assays of Pmar3. (a) 2.29µm 
Pmar3 was incubated with double-strand matched, single-strand, 3' tail and 5' tail 5'-
FAM labelled substrates in duplicates for 8 hours. (b) Pmar3 was de-activated by heating 
at 55oC for 5 minutes. 2.29µm de-activated Pmar3 was incubated with double-strand 




are essential for nuclease activity (Nishino & Morikawa, 2002). As discussed in the 
previous chapter, further work is required to optimize the expression of Pmar3-mut. 
Pmar3-mut will be used in future fluorescence nuclease assays to investigate whether the 
observed nuclease activity can likely be attributed to Pmar3. 
 
3.3.6 Assessing Topoisomerase Activity of Pmar5 
At the commencement of this research, Pmar5 had been annotated as a topoisomerase. 
This was due to its sequence similarity to a viral topoisomerase. The function of Pmar5 
was yet to be confirmed, so we began by assessing its ability to act as a topoisomerase, 
where it would relieve the supercoiling of a pUC19 plasmid.  
 
 
Similarly, to Pmar3, metal-dependency was investigated first by incubating Pmar5 and 
pUC19 with Mg, Mn, and Zn. Figure 3-16 shows no banding in the fractions containing 
Pmar5 and pUC19 with Mg, Mn, or BamHI. There was no shift in apparent size observed 
Figure 3-16: 1% TAE agarose gel of a topoisomerase assay where 6.38µM Pmar5 was 
incubated with 162.4ng pUC19 for 18 hours. Metal-dependent activity was investigated 
by incubating Pmar5 and pUC19 with 5mM MgCl2, 5mM MnCl2 or 10mM ZnCl2. BamHI 
was included as a restriction enzyme control to show the gel-shift when pUC19 is cut. 
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in the Zn-containing reactions, indicating that Pmar5 does not rely on Zn to be active. Mg 
and Mn alone appeared to cut pUC19 without Pmar5 present, shown by an apparent size 
shift in lanes 3 and 5. Top1 was included as a topoisomerase control but appeared to not 
relieve the supercoiling of pUC19 as it was expected to. Topoisomerase activity can be 
visualized as a set of bands decreasing in size appearance, which corresponds to the 
different topologies of pUC19. The pUC19 control shows the expected running size of 
the supercoiled topology, and the BamHI control shows the expected running size of the 
nicked topology. Additional bands between the two controls are expected to be seen in 
topoisomerase-containing samples. These two bands, decreasing in apparent size, are for 
the linear and relaxed topologies. A new batch of pUC19 plasmid was purified and used 
in the remaining assays, given that Top1 did not show clear topoisomerase activity. 
 
 
It was suspected that Pmar5 may have Mg-dependent activity, so a second assay shown 
in Figure 3-17 was run for a shorter time period of 2 hours to see if the supercoiling of 
pUC19 was being relaxed by Pmar5. Three dilutions of Pmar5: 6.38µM (1x), 0.64µM 
(10x dilution), and 0.13µM (50x dilution), were incubated with 5mM MgCl2 and 201.0ng 
pUC19. The ratio of nicked and linear pUC19 to supercoiled pUC19 appeared to decrease 
Figure 3-17: 1% TAE agarose gel of a topoisomerase assay where a dilution series of 
6.38µM (1x), 0.64µM (10x dilution), and 0.13µM (50x dilution) Pmar5 was incubated with 
201.0ng pUC19 and 5mM MgCl2 for 2 hours.  
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with decreasing Pmar5 concentration, indicating that higher concentrations of Pmar5 are 
necessary to relieve supercoiling. 
 
 
The 2-hour assay was repeated with a restriction enzyme control (BamHI) to confirm the 
topology of the bands in the Pmar5-containing reactions. Regardless of Pmar5 
concentration, Pmar5 does not appear to have the same function as Top1, based on the 
banding observed in Figure 3-18. There are two distinct bands in the 1xPmar5 sample: 
the top band shows that Pmar5 may be nicking pUC19, and the bottom band shows that 
Pmar5 appears to be linearizing pUC19 like BamHI. It was hypothesised that Pmar5 may 
be capable of nicking pUC19 but cannot re-join the DNA to create a relaxed plasmid 
topology. Some topoisomerases (e.g. Type IIA) are ATP-dependent, so substrate-
dependency was investigated by incubating Pmar5 with ATP and GTP. 
 
Figure 3-18: 1% TAE agarose gel of a topoisomerase assay where a dilution series of 
6.38µM (1x), 0.64µM (10x dilution), and 0.13µM (50x dilution) Pmar5 was incubated with 
201.0ng pUC19 and 5mM MgCl2 for 2 hours. A restriction enzyme control (BamHI) was 




Figure 3-19 (a and b) compares assays that were run excluding and including a proteinase 
K step respectively. Topoisomerase assays include a proteinase K step to degrade the 
protein and leave only the native structure of the plasmid visible on the gel. By excluding 
proteinase K, we can see any protein-DNA complexes that have formed. Figure 3-19 (a) 
confirms that Pmar5 is binding to pUC19. Figure 3-19 (b) shows that Pmar5 activity is 
not enhanced by ATP or GTP, as lanes 7 and 8 (ATP and GTP) have similar banding 
ratios to lane 4 (no substrates). Pmar5 consistently recognizes the coiled topology of 
pUC19 and cuts the plasmid. However, Pmar5 does not seem to act further on pUC19 
with a linear topology to fully relieve the supercoiling like Top1. A more extensive time 
series of plasmid-based reactions will be carried out in the future to identify if Pmar5 has 
the potential to carry out complete topoisomerase activity after a certain period of time. 
 
We hypothesised that Pmar5 may be part of a more extensive repair pathway and may be 
capable of relieving supercoiling as part of a multi-protein system, and thus form a 
complex with the DNA substrate. To test this hypothesis, Pmar5 was incubated with 
Figure 3-19: 1% TAE agarose gel of a topoisomerase assay where 6.38µM Pmar5 was 
incubated with 197.2ng pUC19 for 2 hours. Lane 1 = pUC19 control, 2 = Pmar5+pUC19, 
3 = Mg control, 4 = Pmar5+Mg+pUC19, 5 = BamHI control, 6 = Pmar5+BamHI, 7 = 
Pmar5+ATP+Mg+pUC19, 8 = Pmar5+GTP+Mg+pUC19, 9 = ATP+Mg+pUC19, 10 = 
GTP+Mg+pUC19, 11 = Top1 control. (a) Assay run without proteinase K incubation step. 
(b) Assay run with proteinase K incubation step. 
(a)               (b) 
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LigW and Pmar3 to see if there were any changes in apparent DNA size observed. Mg 
was omitted so binding and metal-independent interaction could be observed. 
 
 
In Figure 3-20, Top1 (lane 25) successfully relaxed the supercoiled plasmid. The pUC19 
control (lanes 1 and 2) shows that the pUC19 plasmid had no degradation that would be 
caused by nuclease contamination, and there was no gel-shift activity caused by 
proteinase K (lane 1) or the buffer conditions. Lanes 4 shows that Pmar5 bound to pUC19, 
Figure 3-20: 1% TAE agarose gel of a topoisomerase assay where 5µM Pmar3, Pmar5 or 
LigW was incubated with 180.3ng pUC19 for 2 hours. Samples were loaded in order of 
with proteinase K incubation, then without proteinase K incubation. 1 & 2 = pUC19 
control, 3 & 4 = Pmar5 + pUC19, 5 & 6 = LigW + pUC19, 7 & 8 = Pmar3 + pUC19, 9 & 
10 = Pmar5, LigW + pUC19, 11 and 12 = Pmar5, Pmar3 + pUC19, 13 & 14 = LigW, Pmar3 
+ pUC19, 15 & 16 = Pmar5, LigW, Pmar3 + pUC19, 17 & 18 = BamHI + pUC19, 19 & 20 
= Pmar5 + BamHI + pUC19, 21 & 22 = LigW + BamHI + pUC19, 23 & 24 = Pmar3 + 
BamHI + pUC19, 25 & 26 = Top1 + pUC19. 
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which was expected given the previous results. No cutting or topoisomerase activity was 
observed in the absence of MgCl2, confirming that Pmar5 activity is Mg-dependent. In 
contrast to Pmar5, LigW bound to pUC19 and caused a gel-shift only (lane 6), whereas 
Pmar3 did not bind or cut the plasmid, which shows that both LigW and Pmar3 are also 
Mg-dependent. Pmar3 did not bind to the plasmid in the presence of LigW or Pmar5. 
Lane 10 shows a similar shift of Pmar5 and LigW compared to LigW alone, meaning that 
LigW may be blocking Pmar5 from binding to pUC19. However, in lane 12, Pmar3 does 
not appear to block Pmar5 from binding to pUC19. A shift is observed in lane 14 that is 
likely due to LigW binding. However, this shift appears to be smaller than with LigW 
alone (lane 6), suggesting Pmar3 may be possibly blocking LigW from fully binding to 
pUC19.  Lanes 15 and 16 contain Pmar3, Pmar5, and LigW. There appears to be no 
change in activity compared to Pmar5 alone, and the shift in lane 16 is similar to the shift 
observed with only LigW. BamHI cut pUC19 but did not remain bound, as there is no 
gel-shift in lane 18. Lanes 19 and 20 show that BamHI cut pUC19 to produce a linear 
plasmid, and Pmar5 successfully bound to the linear plasmid. This shows that Pmar5 can 
bind to both supercoiled and linear plasmids. LigW and BamHI appeared to work together 
by cutting and re-ligating the plasmid, shown by the double-banding in lane 21. In 
contrast, Pmar3 did not bind to the linear plasmid.   
 
Despite assessing Pmar3 for topoisomerase activity previously, it appears that Pmar3 does 
not bind to pUC19 or enhance the binding and activity of Pmar5. Both LigW and Pmar5 
bound to pUC19 separately yet did not appear to bind together. LigW did not enhance the 
topoisomerase activity of Pmar5. These findings suggest that an undetermined co-factor 
or protein may be required for pUC19 to relieve supercoiling to completion, if this is in 
fact its biological function. In the future, this assay will be repeated with Mg present, as 
Pmar3, Pmar5, and LigW have metal-dependent activity. Once expressed and purified, 
Pmar4 will also be tested in combination with Pmar5 to investigate the relationship 
between these proteins. 
 
3.3.7 Coupled Ligation Assays 
LigW has been found to have significantly lower rates of ligation activity compared to 
other ATP-dependent ligases in P. marinus MIT9312 (Williamson, Unpublished). This 
led to the hypothesis that the proteins on the LigW operon (Pmar3, Pmar4, and Pmar5) 
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may play a role in enhancing the ligation activity of LigW. The ligation activity of Pmar3 
and Pmar5 was assessed by carrying out coupled ligation assays with LigW. 
 
Figure 3-21: 7M Urea gels of coupled ligation assays. LigW was incubated with a nicked 
substrate and (a) Pmar3, and (b) Pmar5, to assess how each adjacent protein interacts 





Figure 3-21 shows that LigW successfully sealed the nick in the nicked substrate, shown 
by a gel shift upwards in the LigW-containing reactions. Pmar3 and Pmar5 appear to not 
display any ligation activity individually, which was expected given the proposed 
nuclease and topoisomerase activities observed respectively. The ratio of nicked to 
repaired substrate appeared to be identical and unchanged by both Pmar3 and Pmar5, 
confirming that ligation activity is not enhanced by these proteins. Other co-factors may 
be required to enhance LigW activity and to activate Pmar3 or Pmar5. Co-factor 
dependency will be explored in the future by repeating these assays with metals and ATP. 
The tested conditions potentially were not favourable for LigW, so this assay will be 
repeated over a range of temperatures and for different time periods. Pmar4 will be tested 
with LigW in the future in addition to testing combinations of Pmar3, Pmar4, and Pmar5, 




Based on the characterization completed during this research, Pmar3 is suspected to be a 
nuclease and Pmar5 shows similar activity to a topoisomerase. Pmar3 appears to be a 
monomeric nuclease with an affinity for single-stranded DNA. Pmar3 had Mg-dependent 
DNA cutting activity and therefore may require Mg or other undetermined co-factors to 
help increase LigW activity. Pmar5 appears to be a pentameric topoisomerase-like 
protein. Pmar5 can recognize and cut pUC19 with a supercoiled topology, but it doesn’t 
relieve supercoiling entirely to give a linear product. Like Pmar3, Pmar5 has Mg-
dependent activity, and therefore may also require Mg or other undetermined co-factors 
to help increase LigW activity.   
 
 
3.5 Future Research 
The suspected nuclease activity of Pmar3 will be confirmed by repeating fluorescence 
nuclease assays with Pmar3-mut to confirm whether the nuclease activity is caused by 
Pmar3 or contaminants. Biochemical characterization of Pmar4 will be carried out in the 
future once Pmar4 is successfully purified. Analytical size-exclusion will be carried out 
to determine the molecular weight of Pmar4. Coupled ligation assays involving Pmar4 
and LigW in addition to combinations of all three proteins with LigW will be completed 
to conclude if any of the proteins are responsible for increasing LigW’s ligation activity. 
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The DNA repair pathway involving Pmar3, Pmar4, Pmar5, and/or LigW remains 
unknown. Further topoisomerase assays will be completed which include Pmar4 coupled 
with Pmar5. It is hypothesised that Pmar5 and Pmar4 may be components of a two-protein 
mechanism for recognizing supercoiled and linear topology respectively. Alternatively, 
Pmar5 may achieve complete topoisomerase function with an unidentified co-factor.  
Given the inconclusive relationship of Pmar5 and LigW, and that Pmar5 can bind to 
pUC19 but not the EMSA nucleotide substrates, the DNA-binding activities of Pmar5 
will be investigated further. Gel filtration of Pmar5, LigW, and pUC19 will be run to 




Conclusions and Future Research 
Prochlorococcus marinus, is one of the most abundant photosynthetic organisms in the 
ocean. P. marinus is thought to contribute towards approximately 8.5% of global ocean 
primary productivity (Laurenceau et al., 2020). P. marinus is of interest because of the 
cell’s simple and unique photosynthetic system, efficient carbon concentrating 
mechanism, and minimal streamlined genome. P. marinus strain MIT9312 thrives in the 
upper euphotic zone where there are minimal nutrients and high levels of UV exposure, 
which would typically put an organism at risk. Little is known about the DNA repair 
genes, proteins, and pathways utilised by Prochlorococcus that enable it to survive in 
these conditions. Researching how DNA repair enzymes among others within 
Prochlorococcus function could help us to understand how it survives under increasingly 
more harmful conditions, such as those caused by climate change.  
 
LigW was found to have low DNA ligase activity on nicked DNA in comparison to other 
ATP-dependent ligases in P. marinus strain MIT9312. The low levels of activity shown 
by LigW make its retention in the small Prochlorococcus genome unusual. LigW, an 
ATP-dependent ligase, appears to be in an operon with other proteins which were 
predicted to promote LigW activity or have their own DNA modifying activities 
(Williamson, Unpublished). The three proteins of interest were annotated as Pmar3, 
Pmar4, and Pmar5, and were the focus of this research. The LigW operon is unique to the 
MIT9312 strain and is part of the flexible genome that makes up the Prochlorococcus 
pan-genome. Since the commencement of this project, 13 new HLII isolates of 
Prochlorococcus were discovered in the western Pacific Ocean and the South China Sea 
by a group from the China University of Geoscience (NCBI accession number: 
PRJNA611498). LigW, Pmar3, and Pmar4 were identified in the sequence of one of these 
strains, named the XMU1402 strain. Pmar5 does not appear to be present in any of the 
new strains. This presents new opportunities for comparative research between the two 
XMU1402 and MIT9312 strains and highlights how active and fast-moving this field of 
research is. 
 
Pmar3 was successfully expressed and purified for characterization. The DNA-specific 
binding activity of Pmar3 remains to be understood, as Pmar3 did not bind to supercoiled 
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or linear pUC19, or the double-stranded, single-stranded, 3’-tail, and 5’-tail DNA 
substrates. However, Pmar3 showed consistent nuclease activity by degrading double-
stranded, single-stranded, 3’-tail, and 5’-tail DNA substrates across multiple purification 
batches and concentrations. A mutant of Pmar3 was designed with four point-mutations 
of aspartate to alanine, to remove the acidic residues that are often conserved in the 
catalytic domain, and are essential for nuclease activity (Nishino & Morikawa, 2002). 
Although successfully transformed, Pmar3-mut was not able to be expressed, meaning 
comparative nuclease assays could not be completed to confirm the nuclease activity of 
Pmar3. The DNA-binding activity and specificity of Pmar3 will be explored further. The 
nuclease activity of Pmar3 will be confirmed by repeating fluorescence nuclease assays 
with Pmar3-mut to confirm whether the nuclease activity is caused by Pmar3 or 
contaminants. Soluble expression and purification of Pmar3-mut will be optimized to 
identify favourable conditions. 
 
Challenges were encountered when attempting to express and purify Pmar4. Soluble 
expression of Pmar4 was not achieved, but the insoluble expression of Pmar4-His was. 
Attempts were made to denature and re-fold Pmar4-His using a Triton-X and urea-based 
IMAC protocol (Palmer & Wingfield, 2012). Pmar4 was unable to be re-folded under the 
tested conditions and therefore was not characterized. Optimization of soluble expression 
and purification of Pmar4 will be continued. Pmar4 will be transformed into different 
expression vectors, to promote soluble expression. Biochemical characterization of 
Pmar4 will be carried out in the future once Pmar4 is successfully purified. 
 
Pmar5 was successfully expressed and purified for characterization. Extensive 
optimization of the Pmar5 purification protocol was essential, as de-tagged Pmar5 was 
unable to be separated from MBP-tagged Pmar5 by size exclusion. This was later 
attributed to Pmar5 being a pentameric protein, which was calculated and confirmed by 
analytical size exclusion. At the commencement of this project, Pmar5 was annotated as 
a topoisomerase based on sequence homology. Characterization of Pmar5 confirmed that 
Pmar5 has partial Mg-dependent topoisomerase activity. Pmar5 consistently bound to and 
nicked supercoiled pUC19 but was unable to completely relax the supercoils like a fully 
functional topoisomerase due to its inability to re-join the DNA. Complete topoisomerase 
activity was not achieved with ATP or GTP co-factors or with Pmar3 and LigW. Further 
topoisomerase assays will be completed which include Pmar4 coupled with Pmar5 and 
other co-factors to help identify what Pmar5 requires to completely relieve the 
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supercoiling of DNA. The DNA-binding activity and specificity of Pmar5 will also be 
investigated further. 
 
Pmar3, Pmar4, and Pmar5 were hypothesised to have DNA-modifying functions, 
including potentially enhancing LigW’s poor ligation activity. Coupled ligation assays of 
Pmar3 and Pmar5 with LigW showed no increase in ligation activity under the tested 
conditions. Undetermined co-factors may be required to promote ligation, but at present, 
the relationship of LigW with each protein remains to be determined. Coupled ligation 
assays involving Pmar4 and LigW in addition to combinations of all three proteins with 
LigW will be completed to conclude if any of the proteins are responsible for increasing 
LigW’s ligation activity. Additionally, crystallization would provide further insight into 
the possible function of these proteins and would allow us to detect more distant 
relationships that these proteins may have. Time constraints did not allow for the 
structural characterization of any of the Prochlorococcus proteins. Crystallization 
requires high concentrations of pure protein, and therefore the optimization of each 
protein’s purification protocol will be the first step taken towards structural 
characterization. Crystallization trials will begin with robot screens to identify any 
favourable conditions that can be used for obtaining crystals for all three proteins.  
 
Attempts to understand each protein’s function beyond DNA repair will be made by 
attempting to construct functional in vivo knockouts of each protein in different strains of 
P. marinus. This will be done to assess the impact of how these changes may affect the 
organism’s ability to survive under light stress. A protocol for gene knockouts in P. 
marinus is currently being developed by The Chisholm Lab with success still to be 
achieved (Laurenceau et al., 2020). An alternative approach that may be explored is 
carrying out in vivo knock-ins of each protein into Synechococcus. This could allow us to 
observe how the proteins impact the organism’s ability to respond to environmental stress. 
Cyanobacteria have proven difficult to manipulate compared to other species of bacteria 
such as Escherichia coli or Bacillus subtilis. This is due to their circadian rhythms, 
restriction and modification systems, and the diversity in ecology, genetics, physiology, 
and morphology that can be seen within a single genus, such as Prochlorococcus (Taton 
et al., 2014). Target gene regulation and expression in cyanobacteria have been studied 
in Synechococcus sp. strain PCC 7002. A promising anhydrotetracycline-dependent 
inducible sRNA system has been developed, which could be useful for manipulating 
cyanobacteria to express a variety of synthetic plasmids (Zess et al., 2016). 
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Synechococcus elongatus strain PCC7942 is another genetically manipulable strain, 
which uses homologous recombination to integrate heterologous sequences into the 
chromosome at knock-in target sites (Taton et al., 2014).  
 
The novel DNA repair pathway involving Pmar3, Pmar4, Pmar5, and/or LigW remains 
yet to be determined. Biochemical and structural characterization of each protein is still 
required, but Pmar3 and Pmar5 are likely to be a nuclease and topoisomerase respectively. 
The research undertaken during this project and the future steps that will be taken will 
make significant contributions towards fully characterizing the unique LigW and its 
adjacent proteins. LigW at present has been successfully characterized as an ATP-
dependent ligase unique to P. marinus MIT9312, yet the extent of its role in DNA repair 
remains to be understood. This research is expected to lead to the discovery of other 
unidentified proteins in Prochlorococcus that aid its survival, as well as in other bacterial 
species. Understanding the function of these proteins is significant for being able to 
identify the DNA repair pathways used by Prochlorococcus. Understanding how DNA 
repair enzymes among others within Prochlorococcus function could help us to utilize 
and engineer bacteria to survive under increasingly more harmful conditions, such as 
those caused by climate change. Once the LigW DNA repair system is characterized, then 
this can be more easily identified and understood in other organisms where it may not be 
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Appendix A: Protein Information 
Protein sequences including N-hexahistidine tag (highlighted in blue) and TEV-site 
(highlighted in green). TEV cleavage occurs between Q and G (red). Mutations from aspartate 
to alanine in Pmar3-mut are highlighted in yellow. 
 




























Appendix B: TEV Cleavage Trials 






4oC, 30min (1:5) 10µl 14µl 16µl 
4oC, 30min (1:10) 10µl 7µl 23µl 
4oC, 1hr (1:5) 10µl 14µl 16µl 
4oC, 1hr (1:10) 10µl 7µl 23µl 
4oC overnight (1:5) 10µl 14µl 16µl 
4oC overnight (1:10) 10µl 7µl 23µl 
RT, 30min (1:5) 10µl 14µl 16µl 
RT, 30min (1:10) 10µl 7µl 23µl 
RT, 1hr (1:5) 10µl 14µl 16µl 
RT, 1hr (1:10) 10µl 7µl 23µl 
RT overnight (1:5) 10µl 14µl 16µl 
RT overnight (1:10) 10µl 7µl 23µl 
37oC, 30min (1:5) 10µl 14µl 16µl 
37oC, 30min (1:10) 10µl 7µl 23µl 
37oC, 1hr (1:5) 10µl 14µl 16µl 
37oC, 1hr (1:10) 10µl 7µl 23µl 
37oC overnight (1:5) 10µl 14µl 16µl 
37oC overnight (1:10) 10µl 7µl 23µl 
RT 30min, 4oC overnight (1:5) 10µl 14µl 16µl 
RT 30min, 4oC overnight (1:10) 10µl 7µl 23µl 
37oC 30min, 4oC overnight (1:5) 10µl 14µl 16µl 
37oC 30min, 4oC overnight (1:10) 10µl 7µl 23µl 
RT 1hr, 4oC overnight (1:5) 10µl 14µl 16µl 
RT 1hr, 4oC overnight (1:10) 10µl 7µl 23µl 
37oC 1hr, 4oC overnight (1:5) 10µl 14µl 16µl 





Appendix C: Additional Purification Results 
 
Figure C-1: Second 12% SDS-PAGE from the size exclusion of LigW. Fractions comprising peak 2 
which contained LigW (43kDa) carried over into lanes 1-4. Lanes 5-9 contain contaminants that were 
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Figure C-2: First IMAC purification and protein analysis of Pmar3-MBP. (a) Chromatogram from 
IMAC of Pmar3-MBP shows the UV absorbance (280nm) and elution of Pmar3-MBP at 15-30% 
buffer B. (b) 15% SDS-PAGE gel shows the presence of Pmar3-MBP (64kDa). All fractions were 
collected, pooled together, and run through a desalting column using buffer C, before being incubated 
with 1mg TEV protease at 4oC overnight. The protein appeared to precipitate overnight, so the lysate 
was separated from precipitants by centrifugation and was used for the reverse IMAC. (c) 15% SDS-
PAGE gels show a low yield of de-tagged Pmar3 (17kDa) was obtained, with inefficient MBP-tag 
cleavage. Flowthrough was pooled and split into two fractions. 1µl benzonase per 10ml lysate and a 
final concentration of 5mM MgCl2 was added to half of the pooled reverse IMAC flowthrough, 500µl 
TEV was added to both halves and was incubated at RT for 30 minutes, then overnight at 4oC. (d and 
e) Reverse IMAC chromatograms for both conditions. (f and g) 15% SDS-PAGE gels for fractions 
from both reverse IMAC’s. Bands are visible in the flowthrough of both lysate at approximately 
17kDa and were suspected to be Pmar3. Protein-containing fractions from both lysates were pooled 
together and concentrated to give a total volume of 5ml which was used for size exclusion. (h) 
Chromatogram for size exclusion of Pmar3. Peak 1-2 = Pmar3-MBP and non-specific proteins, Peak 
3 = Pmar3.  
 
 




(a)             (b) 
(c)             (d) 
(e)             (f) 




Figure C-4: Third IMAC purification and protein analysis of Pmar3-MBP. (a) Chromatogram 
from IMAC of Pmar3-MBP shows the UV absorbance (280nm) and elution of Pmar3-MBP at 
15-55% buffer B. (b) Chromatogram from de-salt of Pmar3-MBP. (c) Chromatogram from the 
first reverse IMAC of Pmar3. This included a buffer A wash before the 20ml 0-100% buffer B 
gradient. (d) 15% SDS-PAGE gel of the flowthrough and elution peak from the reverse IMAC. 
The protein ladder was not visible in this gel. Elution peak contained a high concentration of 
Pmar3-MBP, so the fractions were collected, pooled together, and run through a desalting 
column using buffer C, before being incubated with 1mg TEV protease at 4oC overnight. (e) 
Chromatogram showing the size exclusion of the concentrated flowthrough from the reverse 
IMAC. (f) 15% SDS-PAGE gel showing the separation of Pmar3 (17kDa) from Pmar3-MBP 
(64kDa) and other contaminants. Lanes 8-9 = fractions pooled to give batch “1-P3”. (g) 
Chromatogram from the reverse IMAC of the batch that had a second TEV cleavage step. (h) 
Chromatogram showing the size exclusion of the concentrated flowthrough from the second 
reverse IMAC. (i) 15% SDS-PAGE gel showing the separation of Pmar3 (17kDa) from Pmar3-
MBP (64kDa) and other contaminants. Lanes 9-13 = fractions pooled to give batch “2-P3”. 
 
 
Figure C-5: First IMAC purification and protein analysis of Pmar5. (a) Chromatogram from 
size exclusion of Pmar5. (b) 12% SDS-PAGE gel of size exclusion fractions, confirming the 





Appendix D: Assay Compositions 











FAM-Labelled Oligo 4µl Linear (0.5µM) 
4µl Linear 
(0.5µM) 
4µl Linear (0.5µM) 
4µl Nick FAM 
(0.5µM) 
4µl Nick FAM 
(0.5µM) 
4µl Nick FAM 
(0.5µM) 
Complement 












10x Buffer (500mM 
Tris ph8.0, 500mM 
NaCl, 10mM DTT) 
2.5µl 2.5µl 2.5µl 2.5µl 2.5µl 2.5µl 
MgCl2 (1M) 0.25µl 0.25µl 0.25µl 0.25µl 0.25µl 0.25µl 
MQ 9.25µl 13.25µl 9.25µl 9.25µl 9.25µl 13.25µl 








(2) Single-strand (3) 3’-tail (4) 5’-tail (5) Nicked 
FAM-Labelled 
Oligo 
4µl Linear (0.5µM) 
4µl Linear 
(0.5µM) 
4µl Linear (0.5µM) 
4µl Nick FAM 
(0.5µM) 
4µl Nick FAM 
(0.5µM) 
Complement 










5’ Phos Oligo - - - - 
4µl Nick Phos 
(2.5µM) 
Long Oligo - - - - 
4µl Linear 
(0.5µM) 
EDTA (1M) 0.25µl 0.25µl 0.25µl 0.25µl 0.25µl 
ATP (100mM) 0.25µl 0.25µl 0.25µl 0.25µl 0.25µl 
10x Buffer (500mM 
Tris ph8.0, 500mM 
NaCl, 10mM DTT) 
2.5µl 2.5µl 2.5µl 2.5µl 2.5µl 
MQ 9.25µl 13.25µl 9.25µl 9.25µl 5µl 
Total 20µl 20µl 20µl 20µl 20µl 
 
